[Federal Register Volume 83, Number 33 (Friday, February 16, 2018)]
[Notices]
[Pages 7086-7090]
[FR Doc No: 2018-03202]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-82693; File No. SR-FINRA-2018-003]

Self-Regulatory Organizations; Financial Industry Regulatory
Authority, Inc.; Notice of Filing of a Proposed Rule Change Relating to
Simplified Arbitration

February 12, 2018.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(``Act'') \1\ and Rule 19b-4 thereunder,\2\ notice is hereby given that
on January 29, 2018, Financial Industry Regulatory Authority, Inc.
(``FINRA'') filed with the Securities and Exchange Commission (``SEC''
or ``Commission'') the proposed rule change as described in Items I,
II, and III below, which Items have been prepared by FINRA. The
Commission is publishing this notice to solicit comments on the
proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    FINRA is proposing to amend FINRA Rules 12600 and 12800 of the Code
of Arbitration Procedure for Customer Disputes (``Customer Code'') and
13600 and 13800 of the Code of Arbitration Procedure for Industry
Disputes (``Industry Code,'' and together with the Customer Code, the
``Codes''), to amend the hearing provisions to provide an additional
hearing option for parties in arbitration with claims of $50,000 or
less, excluding interest and expenses.
    The text of the proposed rule change is available on FINRA's
website at http://www.finra.org, at the principal office of FINRA and
at the Commission's Public Reference Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, FINRA included statements
concerning the purpose of and basis for the proposed rule change and
discussed any comments it received on the proposed rule change. The
text of these statements may be examined at the places specified in
Item IV below. FINRA has prepared summaries, set forth in sections A,
B, and C below, of the most significant aspects of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The Codes provide two methods for administering arbitration cases
with claims involving $50,000 or less, excluding interest and expenses.
The default method is a decision by a single arbitrator based on the
parties' pleadings and other materials submitted by the parties. The
alternative method involves a full hearing with a single arbitrator.
Under the Customer Code, a customer may request a hearing (regardless
of whether the customer is a claimant or respondent),\3\ and under the
Industry Code, the claimant may request

a hearing.\4\ If a hearing is requested, it is generally held in-
person, and there are no limits on the number of hearing sessions that
can take place.
---------------------------------------------------------------------------

    \3\ See FINRA Rule 12800(c).
    \4\ See FINRA Rule 13800(c).
---------------------------------------------------------------------------

    FINRA believes that forum users with claims involving $50,000 or
less would benefit by having an additional, intermediate form of
adjudication that would provide them with an opportunity to argue their
cases before an arbitrator in a shorter, limited telephonic hearing
format. Therefore, FINRA is proposing to amend the Codes to include a
Special Proceeding for Simplified Arbitration (``Special Proceeding'').
The Special Proceeding would be limited to two hearing sessions,
exclusive of prehearing conferences,\5\ with parties being given time
limits for their presentations. As discussed above, parties with claims
involving $50,000 or less are currently limited to a decision based on
the pleadings and other materials submitted by the parties, or a full
hearing that typically takes place in-person and is not limited in
duration. While a party might wish for an opportunity to present his or
her case to an arbitrator, the travel and expenses associated with a
full hearing might prevent that party from requesting one. In addition,
the prospect of cross-examination by an opposing party might act as a
deterrent for parties seeking to avoid a direct confrontation with
their opponents. These concerns particularly impact pro se, senior, and
seriously ill parties.
---------------------------------------------------------------------------

    \5\ See FINRA Rules 12100 and 13100 (Definitions). Under these
rules, ``hearing'' means the hearing on the merits of an arbitration
and a ``hearing session'' is defined as any meeting between the
parties and arbitrator(s) of four hours or less, including a hearing
or a prehearing conference.
---------------------------------------------------------------------------

    The suggestion to propose an intermediate form of adjudication
originated from the FINRA Dispute Resolution Task Force (``Task
Force'').\6\ The Task Force observed that customers whose cases were
decided on the papers were the least satisfied of any group of forum
users. They also noted that, from the arbitrator's perspective, it is
more difficult to assess crucial issues of credibility when deciding
cases on the papers. The Task Force recommended that the goal of the
intermediate process should be to give the claimant personal contact
with the arbitrator deciding the case and to give each party the
opportunity to argue its case, to ask questions, and to respond to
contentions from the other side. The Task Force also recommended that
the intermediate process should allow the arbitrator to probe
contentions in the papers in an interactive format.\7\
---------------------------------------------------------------------------

    \6\ The Task Force was formed in 2014 to suggest strategies to
enhance the transparency, impartiality, and efficiency of FINRA's
securities dispute resolution forum. On December 16, 2015, the Task
Force issued its Final Report and Recommendations, available at
http://www.finra.org/sites/default/files/Final-DR-task-force-report.pdf.
    \7\ Id. at 29.
---------------------------------------------------------------------------

    FINRA considered the Task Force's recommendations and questions in
developing the format for an intermediate form of adjudication.\8\
Accordingly, FINRA is proposing to amend Rules 12800(c) and 13800(c) to
provide that parties that opt for a hearing must select between two
hearing options. Option One would be the current hearing option that
provides for the regular provisions of the Codes relating to
prehearings and hearings, including all fee provisions. If the parties
choose Option One, they would continue to have in-person hearings
without time limits, and they would continue to be permitted to
question opposing parties' witnesses.
---------------------------------------------------------------------------

    \8\ The Task Force provided the following questions for FINRA to
consider in developing an intermediate form of adjudication: (1)
Whether parties appearing should be able to amplify positions taken
in their papers and to answer questions posed by the arbitrator; (2)
whether fact witnesses should be permitted to tell their stories to
the arbitrator; (3) whether there should be a clear boundary between
the informal, expedited adjudication and a full-blown hearing; (4)
whether witnesses should be subject to cross-examination by adverse
counsel; (5) whether parties should be able to compel the attendance
of particular witnesses, and if so, should there be a limit; (6)
what arrangements should be made for parties who are not appearing
in person; and (7) whether arbitrators should use the session as an
opportunity to press the parties to settle.
---------------------------------------------------------------------------

    Option Two would be the new Special Proceeding subject to the
regular provisions of the Code relating to prehearings and hearings,
including all fee provisions, with several limiting conditions. The
conditions are intended to ensure that the parties have an opportunity
to present their case to an arbitrator in a convenient and cost
effective manner without being subject to cross-examination by an
opposing party.
    Specifically:
     A Special Proceeding would be held by telephone unless the
parties agree to another method of appearance; \9\
---------------------------------------------------------------------------

    \9\ The Task Force recommended allowing parties with claims
involving $50,000 or less to be able to appear in whatever manner
they prefer: in person, by phone or by videoconference. FINRA
determined that it is in the best interest of the parties to hold
hearings by telephone because this method is the most expeditious
and inexpensive format for hearings. As stated above, FINRA is
proposing that parties can agree to other methods of appearance,
including appearing in person or by videoconference.
---------------------------------------------------------------------------

     the claimants, collectively, would be limited to two hours
to present their case and \1/2\ hour for any rebuttal and closing
statement, exclusive of questions from the arbitrator and responses to
such questions;
     the respondents, collectively, would be limited to two
hours to present their case and \1/2\ hour for any rebuttal and closing
statement, exclusive of questions from the arbitrator and responses to
such questions;
     notwithstanding the abovementioned conditions, the
arbitrator would have the discretion to cede his or her allotted time
to the parties;
     in no event could a Special Proceeding exceed two hearing
sessions, exclusive of prehearing conferences, to be completed in one
day;
     the parties would not be permitted to question the
opposing parties' witnesses;
     the Customer Code would provide that a customer could not
call an opposing party, a current or former associated person of a
member party, or a current or former employee of a member party as a
witness, and members and associated persons could not call a customer
of a member party as a witness; and
     the Industry Code would provide that members and
associated persons could not call an opposing party as a witness.
    Except for the two hearing session time limit for a Special
Proceeding, FINRA would not impose any restrictions on the arbitrator's
ability to ask the parties questions and has incorporated a substantial
amount of time for arbitrator questions. Specifically, since FINRA
would limit the parties' combined presentations to five hours, the
arbitrator would have up to three hours to ask questions. In addition,
under the proposed rule change FINRA would not prohibit the arbitrator
from allowing parties additional time for their presentations or
witness testimonies, so long as the hearing on the merits is completed
within the two hearing session limit.\10\
---------------------------------------------------------------------------

    \10\ The Task Force recommended a shorter time limit on each
case to enable an arbitrator to hear several cases in a hearing day
and to limit the time commitment of the parties. FINRA was concerned
that a period shorter than the proposed two hearing session time
limit would restrict the parties' presentations and their ability to
answer questions posed by the arbitrator.
---------------------------------------------------------------------------

    FINRA is further proposing to amend Rule 12800(a) to add clarity to
the rule by explaining the customer's options earlier in the rule text.
FINRA is proposing to amend the sentence in Rule 12800(c) that states
that ``[I]f no hearing is held, no initial prehearing conference or
other prehearing

conference will be held, and the arbitrator will render an award based
on the pleadings and other materials submitted by the parties.'' FINRA
would replace the first ``held'' in the sentence with the term
``requested'' to better reflect that a hearing would only occur if the
customer requested it. FINRA believes the amendment would add clarity
to the rule text. FINRA is further proposing to amend Rule 12600(a)
that discusses exceptions to when required hearings will be held to
specify Rule 12800(c) as one of the exceptions.
    To add clarity on how arbitrators are paid in cases where the
customer requests a hearing, FINRA is proposing to amend Rule 12800(f)
to clarify that the regular provisions of the Code relating to
arbitrator honoraria would apply in such cases. Since the Special
Proceeding would be a new form of adjudication at the forum, FINRA
intends to provide substantial training to arbitrators including, but
not limited to, updating FINRA's written training materials for
arbitrators, posting a Neutral Workshop video on the FINRA website for
arbitrators to view on-demand, and including discussions about the
Special Proceeding in FINRA's publication for arbitrators and
mediators, The Neutral Corner. FINRA would instruct arbitrators that
the arbitrator's role in a Special Proceeding might be different than
it is in a full hearing because parties would not be permitted to
question opposing parties' witnesses. FINRA would emphasize that in a
Special Proceeding the arbitrator might need to ask more questions than
he or she would ask in a regular hearing to gain clarity on issues and
to assess witness credibility.
2. Statutory Basis
    FINRA believes that the proposed rule change is consistent with the
provisions of Section 15A(b)(6) of the Act,\11\ which requires, among
other things, that FINRA rules must be designed to prevent fraudulent
and manipulative acts and practices, to promote just and equitable
principles of trade, and, in general, to protect investors and the
public interest. As discussed above, the Task Force recommended that
FINRA provide the claimant with an additional cost effective option for
personal contact with the arbitrator deciding the case and give each
party the opportunity to argue its case, to ask questions, and to
respond to contentions from the other side. FINRA believes that the
proposed rule change aligns with the Task Force's recommendations.
---------------------------------------------------------------------------

    \11\ 15 U.S.C. 78o-3(b)(6).
---------------------------------------------------------------------------

    In addition, FINRA believes that the proposed rule change is
consistent with the provisions of the Act because it would provide
parties with claims of $50,000 or less with an additional, cost
effective, hearing option for resolving disputes. FINRA believes that
the proposed rule change would limit the potential costs of a hearing
and provide parties with the opportunity to present their case without
cross-examination from their opponents. The ability to present their
case without cross-examination may benefit those who believe that a
direct confrontation could intimidate their testimony. FINRA believes
that the broader role of arbitrators for a Special Proceeding in asking
questions of the parties would serve a similar function to cross-
examination, such as gaining clarity on issues and assessing witness
credibility, but within a potentially less intimidating environment.

B. Self-Regulatory Organization's Statement on Burden on Competition

    FINRA does not believe that the proposed rule change will result in
any burden on competition that is not necessary or appropriate in
furtherance of the purposes of the Act.
Economic Impact Assessment
(a) Need for the Rule
    As noted above, the Code currently provides two methods for
administering arbitration cases with claims involving $50,000 or less,
excluding interest and expenses. The default method is based
exclusively on the parties' pleadings and other materials submitted by
the parties, and the alternative method involves a full hearing.
Although a full hearing provides the parties a more complete
opportunity to present their cases to an arbitrator, for the reasons
discussed above, the parties sometimes forego a full hearing. The
proposal provides an additional method for administering these
arbitration cases that would allow for oral testimony while limiting
the costs of the proceedings.
(b) Economic Baseline
    The economic baseline for the proposal is the two current methods
for administering arbitration cases with claims involving $50,000 or
less. The proposal is expected to affect customers, either as claimant
or respondent, with a claim involving $50,000 or less; industry
parties, as claimant, with a claim involving $50,000 or less; and
industry parties as respondents to these claims. The proposal is also
expected to affect FINRA arbitrators.
    The parties today that opt for a decision on the pleadings or for a
full hearing face trade-offs between the two choices. A decision on the
pleadings is dependent solely on the parties' pleadings and other
submitted materials, and the cost to parties is generally limited to
filing fees and the legal fees and expenses to submit the materials. On
the other hand, a full hearing is dependent on the pleadings and
submitted materials as well as oral testimony and arguments. In
addition to filing fees and legal fees to submit the materials, parties
can also incur arbitration hearing session fees, travel and lodging
expenses, lost income, and other costs associated with the time spent
at the hearings such as accommodations for dependent care. These costs
increase with the number of hearings and are also dependent on the
characteristics of the parties. For example, parties that live further
away from the hearing site or that are less able to travel will incur
higher travel costs than parties that live closer to the hearing site
or that are more able to travel.\12\ In addition, the costs associated
with the time spent at hearings may be greater for some parties than
for other parties.
---------------------------------------------------------------------------

    \12\ In customer cases, the hearing location will generally be
the location (of FINRA's designated hearing locations) closest to
the investor's residence at the time of the events giving rise to
the dispute. Investors may also seek to change the hearing location
by obtaining the other party's consent or by requesting a change
from FINRA. In industry cases, the hearing location will generally
be the location closest to where the associated person was employed
at the time of the events giving rise to the dispute. FINRA's
hearing locations can be found at: Dispute Resolution Regional
Offices and Hearing Locations.
---------------------------------------------------------------------------

    The costs of a full hearing are greater and more uncertain at the
outset than the costs of a decision on the pleadings. Among other
factors, parties selecting the arbitration format will weigh the
potential benefits of providing testimony and arguments at a full
hearing relative to its higher and more uncertain costs. The greater
and more uncertain costs of a full hearing may cause parties to forego
providing oral testimony and arguments and instead opt for a decision
on the pleadings. Parties also may forego providing oral testimony and
arguments to avoid cross-examination.
    The parties not selecting the arbitration format may instead prefer
a decision on the pleadings. A decision on the pleadings is likely to
minimize their costs and prevents the potential influence of oral
testimony on the award decision. Alternatively, in a full hearing,
these parties are likely to incur greater costs and have exposure to
the potential

persuasive influence of oral testimony and arguments on the award
decision. In either instance, the parties not selecting the arbitration
format would have incentive to settle a dispute and forego arbitration
if the settlement amount and the costs of settling a dispute are less
than the expected arbitration award and the costs of arbitrating the
dispute.
    For arbitration cases with close dates from January 2016 to
December 2016, FINRA staff is able to identify 194 arbitration cases
that had an amount of compensatory relief requested of less than or
equal to $50,000 and were closed through a decision on the pleadings
(154) or by hearing (40).\13\ Of the 40 arbitrations that FINRA staff
identifies as closed by a full hearing, 29 had one or two hearing
sessions, and 11 had three or more hearing sessions. The maximum number
of hearing sessions was eight.
---------------------------------------------------------------------------

    \13\ The 194 arbitration cases were out of a total of 625 that
FINRA staff identified as being closed through a decision on the
pleadings or closed by hearings from January 2016 to December 2016.
Approximately two-thirds of the 194 claims involved a customer as
either a claimant or respondent, but typically as a claimant, and
the remaining one-third of these claims involved a dispute among
industry parties. Among the 40 cases that were closed by a hearing,
approximately one-third involved a customer.
---------------------------------------------------------------------------

(c) Economic Impact
    The Special Proceeding would provide a new third option for
administering arbitration cases with claims involving $50,000 or less,
and would not remove the ability of parties to choose either a decision
on the pleadings or a full hearing. A primary benefit of this new third
option is the increase in the ability of customers and intra-industry
claimants to provide oral testimony but with fewer costs, including the
provision of oral testimony without cross-examination, and with greater
certainty of its length than in a full hearing. In general, a Special
Proceeding would increase the number of options available to customers
and intra-industry claimants in choosing the method which would provide
the most benefits relative to its costs, and would therefore increase
the overall net benefits of the forum to these parties.
    A Special Proceeding would provide customers and intra-industry
claimants the benefit of providing oral testimony to an arbitrator but
subject to several conditions.\14\ These conditions not only limit the
potential costs of the forum (see below), but also provide parties the
opportunity to present their case without cross-examination from their
opponents. The ability to present their case without cross-examination
may benefit those who believe that a direct confrontation could
intimidate their testimony. As a result, arbitrators may play a broader
role in a Special Proceeding in asking questions of the parties that
would serve a similar function to cross-examination, such as gaining
clarity on issues and assessing witness credibility, but within a
potentially less intimidating environment. Arbitrators would need to
spend time and incur any associated costs related to reviewing the
additional training materials for a Special Proceeding.
---------------------------------------------------------------------------

    \14\ A limit to the number of hearings would not only affect the
arbitration fees that parties could incur but also the travel and
lodging expenses, lost income, and other costs associated with the
time spent at the hearings.
---------------------------------------------------------------------------

    Parties to the Special Proceeding are expected to incur lower costs
to participate in the forum than parties to a full hearing,
particularly if the parties proceed by telephonic conference.\15\ The
magnitude of the cost reduction to the parties would be dependent on
their ability to attend hearing sessions in person; parties that reside
further away from a hearing site or that have difficulty traveling
would incur greater costs of an in-person hearing than parties that
reside closer to a hearing site or that have less difficulty traveling.
---------------------------------------------------------------------------

    \15\ FINRA believes that most hearings would proceed by
telephonic conference, thereby saving time and expenses.
---------------------------------------------------------------------------

    A Special Proceeding would also limit the number of hearings, and
the arbitration fees, including hearing session fees, would be based on
the current fee schedule.\16\ The limit on the number of hearing
sessions requires the claimants and respondents to present their case
within the span of one day. As discussed above, 11 of the 40
arbitrations with compensatory damages of less than $50,000 that FINRA
staff identified as closed by a full hearing had three or more hearing
sessions. These arbitrations therefore would have required one or more
days of hearings. Parties to the Special Proceeding would not be
subject to additional days of hearings and its related costs (i.e.,
legal fees and expenses, arbitration fees, lost income, and other costs
associated with the time spent at the hearings), and parties to the
arbitration would also not be subject to the potential delays related
to the scheduling of additional hearings. Relative to a decision on the
pleadings, however, parties would incur additional costs to participate
in a Special Proceeding including legal fees and expenses, arbitration
and hearing session fees, and time.
---------------------------------------------------------------------------

    \16\ The filing fees for claims are the same regardless of the
method chosen to resolve the dispute and are dependent on claim
size. Hearing session fees currently range from $50, for claims up
to $2,500, to $450, for claims greater than $10,000. Parties that
opt for a Special Proceeding or full hearing, in lieu of a decision
on the pleadings, would also incur the other types of arbitration
fees including pre-hearing session fees.
---------------------------------------------------------------------------

    The extent to which the benefits and costs associated with the
forum increase or decrease for claims of $50,000 or less is dependent
on what the parties would have chosen absent this new option. Customers
and intra-industry claimants would have a greater ability to choose the
method based on the trade-off between the potential value of providing
oral testimony and arguments with a corresponding increase in forum
costs.
    The costs incurred by the parties not selecting the arbitration
format could increase or decrease depending on the method that would
have been chosen absent the new option. If the customer or intra-
industry claimant would have chosen a decision on the pleadings, then
the costs to these parties such as arbitration and hearing session fees
would likely increase under a Special Proceeding. They would also have
exposure to the potential influence of oral testimony and arguments on
the award decision. A decision to conduct a Special Proceeding in lieu
of a full hearing would potentially decrease the costs incurred by
these parties through lower hearing session fees and lower costs to
participate in the hearings. To the extent that the Special Proceeding
increases the expected costs of parties not selecting the arbitration
format to participate in the forum and their exposure to the potential
influence of oral testimony, these parties could have additional
impetus to consider settlement.
(d) Alternatives Considered
    FINRA considered a range of alternatives during this process. The
alternatives to the proposal include more or less restrictive limiting
conditions for a Special Proceeding, and providing the new option to a
broader range of claims such as those with higher dollar amounts. As
discussed above, the Task Force recommended allowing parties with
claims involving $50,000 or less to be able to appear in whatever
manner they prefer: In person, by phone or by videoconference. FINRA
determined that it is in the best interest of the parties to hold
hearings by telephone because this method is the most expeditious and
inexpensive format for hearings. As stated above, FINRA is proposing
that parties can agree to other methods of appearance, including
appearing in person or by videoconference. The Task Force also
recommended a shorter time limit on

each case to enable an arbitrator to hear several cases in a hearing
day and to limit the time commitment of the parties. FINRA was
concerned that a period shorter than the proposed two hearing session
time limit would restrict the parties' presentations and their ability
to answer questions posed by the arbitrator. The proposal reflects the
changes that FINRA believes were the most appropriate to propose for
the reasons discussed herein.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    Written comments were neither solicited nor received.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    Within 45 days of the date of publication of this notice in the
Federal Register or within such longer period (i) as the Commission may
designate up to 90 days of such date if it finds such longer period to
be appropriate and publishes its reasons for so finding or (ii) as to
which the self-regulatory organization consents, the Commission will:
    (A) By order approve or disapprove such proposed rule change, or
    (B) institute proceedings to determine whether the proposed rule
change should be disapproved.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's internet comment form (http://www.sec.gov/rules/sro.shtml); or
     Send an email to [email protected]. Please include
File Number SR-FINRA-2018-003 on the subject line.

Paper Comments

     Send paper comments in triplicate to Secretary, Securities
and Exchange Commission, 100 F Street NE, Washington, DC 20549-1090.

All submissions should refer to File Number SR-FINRA-2018-003. This
file number should be included on the subject line if email is used. To
help the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's internet website (http://www.sec.gov/rules/sro.shtml).
Copies of the submission, all subsequent amendments, all written
statements with respect to the proposed rule change that are filed with
the Commission, and all written communications relating to the proposed
rule change between the Commission and any person, other than those
that may be withheld from the public in accordance with the provisions
of 5 U.S.C. 552, will be available for website viewing and printing in
the Commission's Public Reference Room, 100 F Street NE, Washington, DC
20549, on official business days between the hours of 10 a.m. and 3
p.m. Copies of such filing also will be available for inspection and
copying at the principal office of FINRA. All comments received will be
posted without change. Persons submitting comments are cautioned that
we do not redact or edit personal identifying information from comment
submissions. You should submit only information that you wish to make
available publicly. All submissions should refer to File Number SR-
FINRA-2018-003 and should be submitted on or before March 9, 2018.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\17\
---------------------------------------------------------------------------

    \17\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Eduardo A. Aleman,
Assistant Secretary.
[FR Doc. 2018-03202 Filed 2-15-18; 8:45 am]
BILLING CODE 8011-01-P


( P2ucl/ P1ucl)

threshold 99% Flag 90% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 90% Flag 95% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 95% Flag 99% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 99%

P2 > P1 Risk 0.1 P2 > P1 Risk 0.2 P2 > P1 Risk N/ A N/ A N/ A N/ A P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 1.0 P2 > P1 Risk 2.9 P2 Risk 1.0 P2 Risk 2.9 N/ A N/ A N/ A N/ A P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 0.7 N/ A N/ A N/ A N/ A N/ A N/ A N/ A N/ A P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 68 MACT Option MACT or Baseline Comparison Old P1 Category P2/ New P1 Category Chemical Grand Score Grand Score Reliability Count Zero Count P1 Count M1 OPT A Baseline _ MACT OPT C BASELINE _ BASELINE COMP61 ALL_ INCIN P2_ ALL_ LB TEQ 0.35 1.36 0.55 0.28 0.01 OPT C BASELINE _ BASELINE COMP61 ALL_ INCIN P2_ ALL_ LB HG 0.35 1.19 0.60 0.28 0.01 OPT C BASELINE _ BASELINE COMP61 ALL_ INCIN P2_ ALL_ LB CD 0.30 1.19 0.58 0.28 0.03 OPT C BASELINE _ BASELINE COMP61 ALL_ INCIN P2_ ALL_ LB PB 0.30 1.19 0.58 0.28 0.03 OPT C BASELINE _ BASELINE COMP61 ALL_ INCIN P2_ ALL_ LB AS  0.15 1.19 0.56 0.03 0.26 OPT C BASELINE _ BASELINE COMP61 ALL_ INCIN P2_ ALL_ LB BE  0.20 1.19 0.58 0.03 0.28 OPT C BASELINE _ BASELINE COMP61 ALL_ INCIN P2_ ALL_ LB CR_ 6  0.15 1.61 0.60 0.03 0.26 OPT C BASELINE _ BASELINE COMP61 ALL_ INCIN P2_ ALL_ LB CR_ 3  0.15 1.86 0.58 0.03 0.26 OPT C BASELINE _ BASELINE COMP61 ALL_ INCIN P2_ ALL_ LB CL2 0.20 1.56 0.81 0.06 0.01 OPT C BASELINE _ BASELINE COMP61 ALL_ INCIN P2_ ALL_ LB HCL  0.15 1.36 0.60 0.03 0.26 OPT C BASELINE _ BASELINE COMP61 ALL_ INCIN P2_ ALL_ LB SB 0.05 1.19 0.83 0.03 0.03 OPT C BASELINE _ BASELINE COMP61 ALL_ INCIN P2_ ALL_ LB NI  0.15 1.61 0.58 0.03 0.26 OPT C BASELINE _ BASELINE COMP61 ALL_ INCIN P2_ ALL_ LB SE  0.15 1.61 0.60 0.03 0.26 OPT C BASELINE _ BASELINE COMP61 ALL_ INCIN P2_ ALL_ LB BA  0.15 1.31 0.58 0.03 0.26 OPT C BASELINE _ BASELINE COMP61 ALL_ INCIN P2_ ALL_ LB TL  0.15 1.31 0.56 0.03 0.26 OPT C BASELINE _ BASELINE COMP62 ALL_ INCIN P2_ DRY_ LB TEQ 0.14 2.72 0.56 0.04 0.06 OPT C BASELINE _ BASELINE COMP63 ALL_ INCIN P2_ NOTDRY_ LB TEQ 0.41 1.41 0.46 0.29 0.01 OPT C BASELINE _ BASELINE COMP64 ALL_ INCIN P2_ ALL_ SB TEQ 0.00 2.50 0.63 0.00 0.00 OPT C BASELINE _ BASELINE COMP64 ALL_ INCIN P2_ ALL_ SB HG 0.00 3.00 0.80 0.00 0.00 OPT C BASELINE _ BASELINE COMP64 ALL_ INCIN P2_ ALL_ SB CD  0.25 2.75 0.55 0.00 0.25 OPT C BASELINE _ BASELINE COMP64 ALL_ INCIN P2_ ALL_ SB PB 0.00 3.00 0.80 0.00 0.00 OPT C BASELINE _ BASELINE COMP64 ALL_ INCIN P2_ ALL_ SB AS 0.00 3.00 0.78 0.00 0.00 OPT C BASELINE _ BASELINE COMP64 ALL_ INCIN P2_ ALL_ SB BE 0.00 3.00 0.64 0.00 0.00 OPT C BASELINE _ BASELINE COMP64 ALL_ INCIN P2_ ALL_ SB CR_ 6 0.00 2.50 0.57 0.00 0.00 OPT C BASELINE _ BASELINE COMP64 ALL_ INCIN P2_ ALL_ SB CR_ 3 0.00 2.50 0.57 0.00 0.00 OPT C BASELINE _ BASELINE COMP64 ALL_ INCIN P2_ ALL_ SB CL2 0.00 3.00 0.64 0.00 0.00 OPT C BASELINE _ BASELINE COMP64 ALL_ INCIN P2_ ALL_ SB HCL  0.25 2.75 0.53 0.00 0.25 OPT C BASELINE _ BASELINE COMP64 ALL_ INCIN P2_ ALL_ SB SB  0.25 2.75 0.55 0.00 0.25 OPT C BASELINE _ BASELINE COMP64 ALL_ INCIN P2_ ALL_ SB NI  0.50 2.50 0.32 0.00 0.25 OPT C BASELINE _ BASELINE COMP64 ALL_ INCIN P2_ ALL_ SB SE  0.50 2.50 0.32 0.00 0.25 OPT C BASELINE _ BASELINE COMP64 ALL_ INCIN P2_ ALL_ SB BA  0.25 2.75 0.55 0.00 0.25 OPT C BASELINE _ BASELINE COMP64 ALL_ INCIN P2_ ALL_ SB TL  0.25 2.75 0.55 0.00 0.25 OPT C BASELINE _ BASELINE COMP65 ALL_ INCIN P2_ ALL_ HAF TEQ 0.01 2.95 0.83 0.02 0.01 OPT C BASELINE _ BASELINE COMP65 ALL_ INCIN P2_ ALL_ HAF HG 0.01 3.01 0.81 0.02 0.01 OPT C BASELINE _ BASELINE COMP65 ALL_ INCIN P2_ ALL_ HAF CD  0.04 3.16 0.85 0.00 0.01 69 Count 888 Count 999 P2 Pred MOE ( 50%) P2 Pred MOE/ P1 True MOE ( 50%) P2 Pred MOE ( 90%) P2 Pred MOE/ P1 True MOE ( 90%) P2 Pred MOE ( 95%)

0.17 0.00 1E+ 03 4E+ 00 4E+ 01 4E+ 00 2E+ 01 0.12 0.00 6E+ 05 1E+ 01 3E+ 03 1E+ 01 1E+ 03 0.12 0.00 2E+ 05 9E+ 00 4E+ 03 9E+ 00 4E+ 03 0.12 0.00 2E+ 02 9E+ 00 9E+ 01 9E+ 00 9E+ 01 0.15 0.00 1E+ 03 1E 01 1E+ 01 1E 01 1E+ 01 0.12 0.00 2E+ 05 2E 01 2E+ 03 2E 01 2E+ 03 0.12 0.00 5E+ 02 5E 02 3E+ 01 5E 02 5E+ 00 0.13 0.00 1E+ 06 2E 02 6E+ 04 2E 02 4E+ 04 0.12 0.00 3E+ 02 1E+ 00 3E+ 01 1E+ 00 3E+ 01 0.12 0.00 6E+ 02 6E 02 6E+ 01 6E 02 1E+ 01 0.12 0.00 1E+ 03 1E 01 7E+ 00 1E 01 7E+ 00 0.13 0.00 2E+ 03 2E 02 5E+ 02 2E 02 2E+ 02 0.12 0.00 1E+ 05 4E 02 1E+ 03 4E 02 8E+ 02 0.13 0.00 3E+ 02 6E 04 6E+ 00 6E 04 3E+ 00 0.15 0.00 6E+ 02 6E 03 6E+ 01 6E 03 6E+ 00 0.06 0.28 1E+ 01 4E 02 4E 01 4E 02 2E 01 0.23 0.00 2E+ 03 5E+ 00 5E+ 01 5E+ 00 3E+ 01 0.03 0.34 Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE 0.03 0.18 1E+ 03 3E 02 9E+ 00 3E 02 3E+ 00 0.03 0.18 1E+ 02 7E 03 3E+ 00 7E 03 3E+ 00 0.03 0.18 2E 01 1E 02 1E 01 1E 02 1E 01 0.03 0.19 3E+ 01 3E 03 3E 01 3E 03 3E 01 0.03 0.34 2E+ 03 2E 03 2E+ 01 2E 03 2E+ 01 0.03 0.41 Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE 0.03 0.41 Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE 0.03 0.34 1E+ 01 6E 02 1E+ 00 6E 02 1E+ 00 0.03 0.19 3E+ 01 3E 03 3E+ 00 3E 03 6E 01 0.03 0.18 2E+ 01 2E 03 1E 01 2E 03 1E 01 0.03 0.41 1E+ 03 1E 02 2E+ 02 1E 02 1E+ 02 0.03 0.41 Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE 0.03 0.18 1E+ 02 2E 04 2E+ 00 2E 04 1E+ 00 0.03 0.18 7E+ 01 7E 04 7E+ 00 7E 04 7E 01 0.13 0.00 1E+ 01 4E 02 4E 01 4E 02 2E 01 0.16 0.00 5E+ 04 1E+ 00 3E+ 02 1E+ 00 1E+ 02 0.15 0.00 3E+ 03 1E 01 7E+ 01 1E 01 7E+ 01 70 P2 Pred MOE/ P1 True MOE ( 95%) P2 Pred MOE ( 99%) P2 Pred MOE/ P1 True MOE ( 99%) GS/ Rel 0.02 Flag 90% ( P2ucl/ P1ucl) actual/

( P2ucl/ P1ucl)

threshold 90%

OPT A Baseline _ MACT 124 61 19 4E+ 00 4E+ 00 4E+ 00 0.26 1E+ 01 6E+ 02 1E+ 01 0.29 9E+ 00 2E+ 02 9E+ 00 0.25 9E+ 00 7E+ 01 9E+ 00 0.25 1E 01 6E+ 00 1E 01  0.13 P2 > P1 Risk 2E 01 5E+ 02 2E 01  0.17 P2 > P1 Risk 5E 02 1E+ 00 5E 02  0.09 P2 > P1 Risk 2E 02 2E+ 04 2E 02  0.08 P2 > P1 Risk 1E+ 00 7E+ 00 1E+ 00 0.13 6E 02 6E+ 00 6E 02  0.11 P2 > P1 Risk 1E 01 N/ A N/ A 0.04 2E 02 2E+ 01 2E 02  0.09 P2 > P1 Risk 4E 02 4E+ 02 4E 02  0.09 P2 > P1 Risk 6E 04 3E+ 00 6E 04  0.11 P2 > P1 Risk 0.2 6E 03 6E 01 6E 03  0.11 P2 > P1 Risk 4E 02 4E 02 4E 02 0.05 P2 > P1 Risk 2.5 5E+ 00 5E+ 00 5E+ 00 0.29 Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE 0.00 N/ A 3E 02 1E+ 00 3E 02 0.00 P2 > P1 Risk 0.1 7E 03 1E 01 7E 03  0.09 P2 > P1 Risk 0.3 1E 02 8E 02 1E 02 0.00 P2 > P1 Risk 9.9 3E 03 2E 01 3E 03 0.00 P2 > P1 Risk 3.2 2E 03 5E+ 00 2E 03 0.00 P2 > P1 Risk Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE 0.00 N/ A Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE 0.00 N/ A 6E 02 3E 01 6E 02 0.00 P2 > P1 Risk 0.9 3E 03 3E 01 3E 03  0.09 P2 > P1 Risk 0.4 2E 03 N/ A N/ A  0.09 P2 > P1 Risk 8.5 1E 02 1E+ 01 1E 02  0.20 P2 > P1 Risk Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE  0.20 N/ A 2E 04 1E+ 00 2E 04  0.09 P2 > P1 Risk 0.4 7E 04 7E 02 7E 04  0.09 P2 > P1 Risk 0.1 4E 02 4E 02 4E 02 0.00 P2 > P1 Risk 2.3 1E+ 00 5E+ 01 1E+ 00 0.00 1E 01 3E+ 00 1E 01  0.01 P2 > P1 Risk 71 Flag 95% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 95% Flag 99% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 99% Flag 90% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 90% Flag 95% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 95% Flag 99% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 99%

61 25 57 30 5 5 10 10 14 14 P2 > P1 Risk P2 > P1 Risk 0.2 P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 0.2 P2 > P1 Risk 1.0 P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 0.2 N/ A N/ A N/ A N/ A P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 0.3 P2 > P1 Risk 0.3 P2 > P1 Risk 0.2 P2 > P1 Risk 1.6 P2 Risk 1.6 P2 > P1 Risk 5.0 P2 > P1 Risk 25.2 P2 Risk 2.5 P2 Risk 5.0 P2 Risk 25.2 N/ A N/ A N/ A N/ A N/ A P2 > P1 Risk 0.3 P2 > P1 Risk 0.7 P2 > P1 Risk 0.3 P2 > P1 Risk 7.4 P2 Risk 7.4 P2 > P1 Risk 9.9 P2 > P1 Risk 12.4 P2 Risk 9.9 P2 Risk 9.9 P2 Risk 12.4 P2 > P1 Risk 3.2 P2 > P1 Risk 6.5 P2 Risk 3.2 P2 Risk 3.2 P2 Risk 6.5 P2 > P1 Risk P2 > P1 Risk 0.2 N/ A N/ A N/ A N/ A N/ A N/ A N/ A N/ A N/ A N/ A P2 > P1 Risk 0.9 P2 > P1 Risk 3.6 P2 Risk 3.6 P2 > P1 Risk 1.8 P2 > P1 Risk 3.5 P2 Risk 1.8 P2 Risk 3.5 P2 > P1 Risk 8.5 N/ A N/ A P2 Risk 8.5 P2 Risk 8.5 N/ A N/ A P2 > P1 Risk P2 > P1 Risk N/ A N/ A N/ A N/ A N/ A P2 > P1 Risk 0.9 P2 > P1 Risk 0.9 P2 > P1 Risk 1.4 P2 > P1 Risk 14.5 P2 Risk 1.4 P2 Risk 14.5 P2 > P1 Risk 4.6 P2 > P1 Risk 22.9 P2 Risk 2.3 P2 Risk 4.6 P2 Risk 22.9 P2 > P1 Risk P2 > P1 Risk 0.4 72 MACT Option MACT or Baseline Comparison Old P1 Category P2/ New P1 Category Chemical Grand Score Grand Score Reliability Count Zero Count P1 Count M1 OPT C BASELINE _ BASELINE COMP65 ALL_ INCIN P2_ ALL_ HAF PB 0.20 2.89 0.61 0.25 0.01 OPT C BASELINE _ BASELINE COMP65 ALL_ INCIN P2_ ALL_ HAF AS  0.04 3.16 0.85 0.00 0.01 OPT C BASELINE _ BASELINE COMP65 ALL_ INCIN P2_ ALL_ HAF BE  0.04 3.16 0.81 0.00 0.01 OPT C BASELINE _ BASELINE COMP65 ALL_ INCIN P2_ ALL_ HAF CR_ 6  0.55 1.84 0.33 0.00 0.26 OPT C BASELINE _ BASELINE COMP65 ALL_ INCIN P2_ ALL_ HAF CR_ 3  0.05 2.84 0.58 0.00 0.01 OPT C BASELINE _ BASELINE COMP65 ALL_ INCIN P2_ ALL_ HAF CL2  0.24 2.56 0.53 0.02 0.26 OPT C BASELINE _ BASELINE COMP65 ALL_ INCIN P2_ ALL_ HAF HCL  0.04 2.91 0.85 0.00 0.01 OPT C BASELINE _ BASELINE COMP65 ALL_ INCIN P2_ ALL_ HAF SB 0.04 2.64 0.72 0.04 0.02 OPT C BASELINE _ BASELINE COMP65 ALL_ INCIN P2_ ALL_ HAF NI  0.29 2.66 0.60 0.00 0.26 OPT C BASELINE _ BASELINE COMP65 ALL_ INCIN P2_ ALL_ HAF SE  0.09 3.01 0.78 0.00 0.02 OPT C BASELINE _ BASELINE COMP65 ALL_ INCIN P2_ ALL_ HAF BA  0.10 2.98 0.80 0.00 0.02 OPT C BASELINE _ BASELINE COMP65 ALL_ INCIN P2_ ALL_ HAF TL  0.34 2.76 0.58 0.00 0.27 OPT C BASELINE _ BASELINE COMP66 ALL_ INCIN NEW_ P1_ ALL_ INCIN TEQ 0.24 1.31 0.73 0.25 0.00 OPT C BASELINE _ BASELINE COMP66 ALL_ INCIN NEW_ P1_ ALL_ INCIN HG 0.00 1.56 0.99 0.00 0.00 OPT C BASELINE _ BASELINE COMP66 ALL_ INCIN NEW_ P1_ ALL_ INCIN CD 0.25 1.19 0.74 0.25 0.00 OPT C BASELINE _ BASELINE COMP66 ALL_ INCIN NEW_ P1_ ALL_ INCIN PB 0.25 1.19 0.74 0.25 0.00 OPT C BASELINE _ BASELINE COMP66 ALL_ INCIN NEW_ P1_ ALL_ INCIN AS 0.05 1.44 0.97 0.02 0.00 OPT C BASELINE _ BASELINE COMP66 ALL_ INCIN NEW_ P1_ ALL_ INCIN BE 0.25 1.44 0.74 0.25 0.00 OPT C BASELINE _ BASELINE COMP66 ALL_ INCIN NEW_ P1_ ALL_ INCIN CR_ 6 0.20 1.31 0.69 0.25 0.02 OPT C BASELINE _ BASELINE COMP66 ALL_ INCIN NEW_ P1_ ALL_ INCIN CR_ 3 0.20 1.31 0.72 0.25 0.02 OPT C BASELINE _ BASELINE COMP66 ALL_ INCIN NEW_ P1_ ALL_ INCIN CL2 0.23 1.44 0.70 0.27 0.02 OPT C BASELINE _ BASELINE COMP66 ALL_ INCIN NEW_ P1_ ALL_ INCIN HCL 0.00 1.44 0.99 0.00 0.00 OPT C BASELINE _ BASELINE COMP66 ALL_ INCIN NEW_ P1_ ALL_ INCIN SB 0.25 1.56 0.74 0.25 0.00 OPT C BASELINE _ BASELINE COMP66 ALL_ INCIN NEW_ P1_ ALL_ INCIN NI 0.25 1.31 0.72 0.25 0.00 OPT C BASELINE _ BASELINE COMP66 ALL_ INCIN NEW_ P1_ ALL_ INCIN SE 0.00 1.56 0.99 0.00 0.00 OPT C BASELINE _ BASELINE COMP66 ALL_ INCIN NEW_ P1_ ALL_ INCIN BA 0.31 1.50 0.72 0.27 0.00 OPT C BASELINE _ BASELINE COMP66 ALL_ INCIN NEW_ P1_ ALL_ INCIN TL 0.00 1.56 0.99 0.00 0.00 OPT C BASELINE _ BASELINE COMP67 ALL_ INCIN NEW_ P1_ DRY_ ALL_ INCIN TEQ  0.33 2.60 0.70 0.00 0.27 OPT C BASELINE _ BASELINE COMP68 ALL_ INCIN NEW_ P1_ NOTDRY_ ALL_ INCIN TEQ 0.25 1.49 0.66 0.25 0.00 OPT C BASELINE _ BASELINE COMP69 ALL_ INCIN P2_ ALL_ SB_ LB TEQ 0.35 1.36 0.55 0.28 0.01 OPT C BASELINE _ BASELINE COMP69 ALL_ INCIN P2_ ALL_ SB_ LB HG 0.11 1.44 0.85 0.03 0.01 OPT C BASELINE _ BASELINE COMP69 ALL_ INCIN P2_ ALL_ SB_ LB CD 0.36 1.19 0.60 0.28 0.01 OPT C BASELINE _ BASELINE COMP69 ALL_ INCIN P2_ ALL_ SB_ LB PB 0.31 1.19 0.59 0.28 0.03 OPT C BASELINE _ BASELINE COMP69 ALL_ INCIN P2_ ALL_ SB_ LB AS  0.14 1.19 0.60 0.03 0.26 OPT C BASELINE _ BASELINE COMP69 ALL_ INCIN P2_ ALL_ SB_ LB BE  0.19 1.19 0.59 0.03 0.28 OPT C BASELINE _ BASELINE COMP69 ALL_ INCIN P2_ ALL_ SB_ LB CR_ 6  0.14 1.61 0.60 0.03 0.26 OPT C BASELINE _ BASELINE COMP69 ALL_ INCIN P2_ ALL_ SB_ LB CR_ 3  0.14 1.86 0.59 0.03 0.26 73 Count 888 Count 999 P2 Pred MOE ( 50%) P2 Pred MOE/ P1 True MOE ( 50%) P2 Pred MOE ( 90%) P2 Pred MOE/ P1 True MOE ( 90%) P2 Pred MOE ( 95%)

0.13 0.00 6E+ 01 3E+ 00 3E+ 01 3E+ 00 3E+ 01 0.15 0.00 4E+ 03 4E 01 4E+ 01 4E 01 4E+ 01 0.18 0.00 4E+ 05 4E 01 4E+ 03 4E 01 4E+ 03 0.15 0.27 4E+ 03 4E 01 2E+ 02 4E 01 4E+ 01 0.15 0.27 8E+ 06 2E 01 5E+ 05 2E 01 3E+ 05 0.20 0.00 1E+ 01 7E 02 1E+ 00 7E 02 1E+ 00 0.15 0.00 3E+ 02 3E 02 3E+ 01 3E 02 6E+ 00 0.20 0.02 3E+ 03 3E 01 2E+ 01 3E 01 2E+ 01 0.15 0.00 8E+ 03 8E 02 2E+ 03 8E 02 8E+ 02 0.20 0.00 2E+ 04 6E 03 2E+ 02 6E 03 1E+ 02 0.16 0.02 3E+ 04 6E 02 6E+ 02 6E 02 3E+ 02 0.15 0.00 3E+ 03 3E 02 3E+ 02 3E 02 3E+ 01 0.02 0.00 2E+ 03 7E+ 00 7E+ 01 7E+ 00 3E+ 01 0.01 0.00 3E+ 04 5E 01 2E+ 02 5E 01 5E+ 01 0.01 0.00 3E+ 05 2E+ 01 8E+ 03 2E+ 01 8E+ 03 0.01 0.00 3E+ 02 1E+ 01 1E+ 02 1E+ 01 1E+ 02 0.01 0.00 2E+ 04 2E+ 00 2E+ 02 2E+ 00 2E+ 02 0.01 0.00 1E+ 06 1E+ 00 1E+ 04 1E+ 00 1E+ 04 0.04 0.00 4E+ 04 4E+ 00 2E+ 03 4E+ 00 4E+ 02 0.01 0.00 3E+ 08 6E+ 00 2E+ 07 6E+ 00 1E+ 07 0.01 0.00 5E+ 02 2E+ 00 5E+ 01 2E+ 00 5E+ 01 0.01 0.00 1E+ 04 1E+ 00 1E+ 03 1E+ 00 2E+ 02 0.01 0.00 3E+ 04 3E+ 00 1E+ 02 3E+ 00 1E+ 02 0.03 0.00 2E+ 05 2E+ 00 4E+ 04 2E+ 00 2E+ 04 0.01 0.00 4E+ 05 1E 01 4E+ 03 1E 01 3E+ 03 0.01 0.00 8E+ 05 2E+ 00 2E+ 04 2E+ 00 8E+ 03 0.01 0.00 3E+ 04 3E 01 3E+ 03 3E 01 3E+ 02 0.03 0.00 5E+ 01 2E 01 2E+ 00 2E 01 8E 01 0.09 0.00 5E+ 03 2E+ 01 2E+ 02 2E+ 01 8E+ 01 0.17 0.00 1E+ 03 4E+ 00 4E+ 01 4E+ 00 2E+ 01 0.11 0.00 7E+ 04 1E+ 00 4E+ 02 1E+ 00 1E+ 02 0.11 0.00 3E+ 04 2E+ 00 8E+ 02 2E+ 00 8E+ 02 0.11 0.00 1E+ 02 6E+ 00 6E+ 01 6E+ 00 6E+ 01 0.11 0.00 1E+ 03 1E 01 1E+ 01 1E 01 1E+ 01 0.11 0.00 2E+ 05 2E 01 2E+ 03 2E 01 2E+ 03 0.11 0.00 5E+ 02 5E 02 3E+ 01 5E 02 5E+ 00 0.13 0.00 1E+ 06 2E 02 6E+ 04 2E 02 4E+ 04 74 P2 Pred MOE/ P1 True MOE ( 95%) P2 Pred MOE ( 99%) P2 Pred MOE/ P1 True MOE ( 99%) GS/ Rel 0.02 Flag 90% ( P2ucl/ P1ucl) actual/

( P2ucl/ P1ucl)

threshold 90%

3E+ 00 3E+ 01 3E+ 00 0.07 4E 01 2E+ 01 4E 01  0.01 P2 > P1 Risk 4E 01 1E+ 03 4E 01  0.01 P2 > P1 Risk 4E 01 8E+ 00 4E 01  0.30 P2 > P1 Risk 2E 01 2E+ 05 2E 01  0.02 P2 > P1 Risk 7E 02 4E 01 7E 02  0.09 P2 > P1 Risk 0.7 3E 02 3E+ 00 3E 02  0.01 P2 > P1 Risk 3E 01 N/ A N/ A 0.01 P2 > P1 Risk 8E 02 8E+ 01 8E 02  0.11 P2 > P1 Risk 6E 03 6E+ 01 6E 03  0.03 P2 > P1 Risk 6E 02 3E+ 02 6E 02  0.03 P2 > P1 Risk 3E 02 3E+ 00 3E 02  0.12 P2 > P1 Risk 7E+ 00 7E+ 00 7E+ 00 0.18 5E 01 3E+ 01 5E 01 0.00 P2 > P1 Risk 2E+ 01 3E+ 02 2E+ 01 0.21 1E+ 01 1E+ 02 1E+ 01 0.21 2E+ 00 1E+ 02 2E+ 00 0.03 1E+ 00 3E+ 03 1E+ 00 0.17 4E+ 00 8E+ 01 4E+ 00 0.15 6E+ 00 6E+ 06 6E+ 00 0.15 2E+ 00 1E+ 01 2E+ 00 0.16 1E+ 00 1E+ 02 1E+ 00 0.00 3E+ 00 N/ A N/ A 0.16 2E+ 00 2E+ 03 2E+ 00 0.19 1E 01 1E+ 03 1E 01 0.00 P2 > P1 Risk 2E+ 00 8E+ 03 2E+ 00 0.21 3E 01 3E+ 01 3E 01 0.00 P2 > P1 Risk 2E 01 2E 01 2E 01  0.13 P2 > P1 Risk 0.6 2E+ 01 2E+ 01 2E+ 01 0.17 4E+ 00 4E+ 00 4E+ 00 0.26 1E+ 00 7E+ 01 1E+ 00 0.08 2E+ 00 3E+ 01 2E+ 00 0.31 6E+ 00 4E+ 01 6E+ 00 0.26 1E 01 6E+ 00 1E 01  0.12 P2 > P1 Risk 2E 01 5E+ 02 2E 01  0.16 P2 > P1 Risk 5E 02 1E+ 00 5E 02  0.09 P2 > P1 Risk 2E 02 2E+ 04 2E 02  0.07 P2 > P1 Risk 75 Flag 95% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 95% Flag 99% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 99% Flag 90% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 90% Flag 95% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 95% Flag 99% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 99%

P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 0.1 P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 0.7 P2 > P1 Risk 2.8 P2 Risk 2.8 P2 > P1 Risk 0.2 P2 > P1 Risk 0.3 P2 > P1 Risk N/ A N/ A N/ A N/ A P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 0.4 P2 > P1 Risk P2 > P1 Risk N/ A N/ A N/ A N/ A P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 1.3 P2 > P1 Risk 6.4 P2 Risk 1.3 P2 Risk 6.4 P2 > P1 Risk P2 > P1 Risk 0.2 P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 0.2 P2 > P1 Risk 1.0 P2 > P1 Risk P2 > P1 Risk 76 MACT Option MACT or Baseline Comparison Old P1 Category P2/ New P1 Category Chemical Grand Score Grand Score Reliability Count Zero Count P1 Count M1 OPT C BASELINE _ BASELINE COMP69 ALL_ INCIN P2_ ALL_ SB_ LB CL2 0.21 1.56 0.82 0.06 0.01 OPT C BASELINE _ BASELINE COMP69 ALL_ INCIN P2_ ALL_ SB_ LB HCL  0.14 1.36 0.60 0.03 0.26 OPT C BASELINE _ BASELINE COMP69 ALL_ INCIN P2_ ALL_ SB_ LB SB 0.11 1.19 0.85 0.03 0.01 OPT C BASELINE _ BASELINE COMP69 ALL_ INCIN P2_ ALL_ SB_ LB NI  0.14 1.49 0.60 0.03 0.26 OPT C BASELINE _ BASELINE COMP69 ALL_ INCIN P2_ ALL_ SB_ LB SE  0.14 1.61 0.60 0.03 0.26 OPT C BASELINE _ BASELINE COMP69 ALL_ INCIN P2_ ALL_ SB_ LB BA  0.14 1.19 0.57 0.03 0.26 OPT C BASELINE _ BASELINE COMP69 ALL_ INCIN P2_ ALL_ SB_ LB TL  0.14 1.19 0.57 0.03 0.26 OPT C BASELINE _ BASELINE COMP70 CK NEW_ P1_ ALL_ CK TEQ 0.31 3.19 0.73 0.27 0.00 OPT C BASELINE _ BASELINE COMP70 CK NEW_ P1_ ALL_ CK HG  0.25 3.63 0.73 0.00 0.25 OPT C BASELINE _ BASELINE COMP70 CK NEW_ P1_ ALL_ CK CD 0.25 3.13 0.75 0.25 0.00 OPT C BASELINE _ BASELINE COMP70 CK NEW_ P1_ ALL_ CK PB 0.25 3.13 0.75 0.25 0.00 OPT C BASELINE _ BASELINE COMP70 CK NEW_ P1_ ALL_ CK AS 0.25 3.38 0.75 0.25 0.00 OPT C BASELINE _ BASELINE COMP70 CK NEW_ P1_ ALL_ CK BE 0.25 3.13 0.75 0.25 0.00 OPT C BASELINE _ BASELINE COMP70 CK NEW_ P1_ ALL_ CK CR_ 6 0.00 3.88 0.94 0.00 0.00 OPT C BASELINE _ BASELINE COMP70 CK NEW_ P1_ ALL_ CK CR_ 3 0.25 3.13 0.75 0.25 0.00 OPT C BASELINE _ BASELINE COMP70 CK NEW_ P1_ ALL_ CK CL2 0.00 3.88 0.96 0.00 0.00 OPT C BASELINE _ BASELINE COMP70 CK NEW_ P1_ ALL_ CK HCL 0.25 3.13 0.75 0.25 0.00 OPT C BASELINE _ BASELINE COMP70 CK NEW_ P1_ ALL_ CK SB 0.00 3.88 1.00 0.00 0.00 OPT C BASELINE _ BASELINE COMP70 CK NEW_ P1_ ALL_ CK NI 0.25 3.63 0.71 0.25 0.00 OPT C BASELINE _ BASELINE COMP70 CK NEW_ P1_ ALL_ CK SE 0.00 3.88 1.00 0.00 0.00 OPT C BASELINE _ BASELINE COMP70 CK NEW_ P1_ ALL_ CK BA 0.00 3.88 1.00 0.00 0.00 OPT C BASELINE _ BASELINE COMP70 CK NEW_ P1_ ALL_ CK TL 0.00 3.88 1.00 0.00 0.00 OPT C BASELINE _ BASELINE COMP71 LWAK NEW_ P1_ ALL_ LWAK TEQ 0.00 2.00 0.50 0.00 0.00 OPT C BASELINE _ BASELINE COMP71 LWAK NEW_ P1_ ALL_ LWAK HG  0.50 1.50 0.25 0.00 0.25 OPT C BASELINE _ BASELINE COMP71 LWAK NEW_ P1_ ALL_ LWAK CD 0.50 1.50 0.25 0.25 0.00 OPT C BASELINE _ BASELINE COMP71 LWAK NEW_ P1_ ALL_ LWAK PB 0.00 2.00 0.50 0.00 0.00 OPT C BASELINE _ BASELINE COMP71 LWAK NEW_ P1_ ALL_ LWAK AS 0.00 2.00 0.50 0.00 0.00 OPT C BASELINE _ BASELINE COMP71 LWAK NEW_ P1_ ALL_ LWAK BE 0.00 2.00 0.50 0.00 0.00 OPT C BASELINE _ BASELINE COMP71 LWAK NEW_ P1_ ALL_ LWAK CR_ 6 0.00 2.00 0.50 0.00 0.00 OPT C BASELINE _ BASELINE COMP71 LWAK NEW_ P1_ ALL_ LWAK CR_ 3 0.00 2.00 0.50 0.00 0.00 OPT C BASELINE _ BASELINE COMP71 LWAK NEW_ P1_ ALL_ LWAK CL2 0.50 1.50 0.25 0.25 0.00 OPT C BASELINE _ BASELINE COMP71 LWAK NEW_ P1_ ALL_ LWAK HCL 0.50 1.50 0.25 0.25 0.00 OPT C BASELINE _ BASELINE COMP71 LWAK NEW_ P1_ ALL_ LWAK SB 0.50 1.50 0.25 0.25 0.00 OPT C BASELINE _ BASELINE COMP71 LWAK NEW_ P1_ ALL_ LWAK NI 0.00 2.00 0.50 0.00 0.00 OPT C BASELINE _ BASELINE COMP71 LWAK NEW_ P1_ ALL_ LWAK SE 0.00 2.00 0.50 0.00 0.00 OPT C BASELINE _ BASELINE COMP71 LWAK NEW_ P1_ ALL_ LWAK BA 0.00 2.00 0.50 0.00 0.00 OPT C BASELINE _ BASELINE COMP71 LWAK NEW_ P1_ ALL_ LWAK TL 0.00 2.00 0.50 0.00 0.00 77 Count 888 Count 999 P2 Pred MOE ( 50%) P2 Pred MOE/ P1 True MOE ( 50%) P2 Pred MOE ( 90%) P2 Pred MOE/ P1 True MOE ( 90%) P2 Pred MOE ( 95%)

0.11 0.00 1E+ 02 6E 01 1E+ 01 6E 01 1E+ 01 0.11 0.00 4E+ 02 4E 02 4E+ 01 4E 02 8E+ 00 0.11 0.00 4E+ 03 4E 01 2E+ 01 4E 01 2E+ 01 0.11 0.00 2E+ 03 2E 02 5E+ 02 2E 02 2E+ 02 0.11 0.00 1E+ 05 4E 02 1E+ 03 4E 02 8E+ 02 0.14 0.00 3E+ 02 6E 04 6E+ 00 6E 04 3E+ 00 0.14 0.00 6E+ 02 6E 03 6E+ 01 6E 03 6E+ 00 0.00 0.00 3E+ 02 6E+ 00 3E+ 01 6E+ 00 2E+ 01 0.02 0.00 2E+ 01 4E 01 1E+ 00 4E 01 8E 01 0.00 0.00 2E+ 04 8E+ 00 4E+ 03 8E+ 00 2E+ 03 0.00 0.00 1E+ 03 2E+ 01 6E+ 02 2E+ 01 4E+ 02 0.00 0.00 8E+ 04 4E+ 00 4E+ 03 4E+ 00 4E+ 03 0.00 0.00 7E+ 06 7E+ 00 1E+ 05 7E+ 00 1E+ 05 0.05 0.00 2E+ 04 2E+ 00 2E+ 04 2E+ 00 2E+ 04 0.00 0.00 4E+ 07 2E+ 00 1E+ 07 2E+ 00 4E+ 06 0.04 0.00 1E+ 02 4E 01 9E+ 00 4E 01 9E+ 00 0.00 0.00 2E+ 03 2E+ 00 7E+ 02 2E+ 00 5E+ 02 0.00 0.00 6E+ 05 6E 01 6E+ 02 6E 01 6E+ 02 0.04 0.00 9E+ 04 9E 01 9E+ 03 9E 01 4E+ 03 0.00 0.00 8E+ 03 8E 01 2E+ 03 8E 01 8E+ 02 0.00 0.00 3E+ 03 6E 02 1E+ 02 6E 02 6E+ 01 0.00 0.00 6E+ 03 6E 01 3E+ 02 6E 01 6E+ 01 0.00 0.50 1E+ 01 7E 01 2E+ 00 7E 01 1E+ 00 0.00 0.50 9E+ 02 2E+ 00 9E+ 01 2E+ 00 3E+ 01 0.00 0.50 5E+ 05 2E+ 01 5E+ 04 2E+ 01 2E+ 04 0.00 0.50 5E+ 03 5E+ 00 2E+ 03 5E+ 00 2E+ 03 0.00 0.50 2E+ 04 2E+ 00 5E+ 03 2E+ 00 3E+ 03 0.00 0.50 1E+ 06 3E+ 00 2E+ 05 3E+ 00 2E+ 05 0.00 0.50 3E+ 04 8E 01 3E+ 03 8E 01 2E+ 03 0.00 0.50 4E+ 07 4E+ 00 1E+ 07 4E+ 00 7E+ 06 0.00 0.50 1E+ 04 1E+ 01 1E+ 03 1E+ 01 9E+ 02 0.00 0.50 4E+ 02 4E+ 00 2E+ 02 4E+ 00 1E+ 02 0.00 0.50 3E+ 06 3E+ 01 3E+ 05 3E+ 01 3E+ 05 0.00 0.50 2E+ 05 4E+ 00 1E+ 04 4E+ 00 4E+ 03 0.00 0.50 3E+ 05 5E 01 2E+ 05 5E 01 5E+ 04 0.00 0.50 1E+ 06 3E+ 00 6E+ 04 3E+ 00 6E+ 04 0.00 0.50 9E+ 04 9E 01 3E+ 04 9E 01 2E+ 04 78 P2 Pred MOE/ P1 True MOE ( 95%) P2 Pred MOE ( 99%) P2 Pred MOE/ P1 True MOE ( 99%) GS/ Rel 0.02 Flag 90% ( P2ucl/ P1ucl) actual/

( P2ucl/ P1ucl)

threshold 90%

6E 01 3E+ 00 6E 01 0.14 4E 02 4E+ 00 4E 02  0.10 P2 > P1 Risk 4E 01 N/ A N/ A 0.09 2E 02 2E+ 01 2E 02  0.09 P2 > P1 Risk 4E 02 4E+ 02 4E 02  0.09 P2 > P1 Risk 6E 04 3E+ 00 6E 04  0.12 P2 > P1 Risk 0.2 6E 03 6E 01 6E 03  0.12 P2 > P1 Risk 6E+ 00 9E+ 00 6E+ 00 0.10 4E 01 5E 01 4E 01  0.07 P2 > P1 Risk 0.8 8E+ 00 8E+ 02 8E+ 00 0.08 2E+ 01 4E+ 02 2E+ 01 0.08 4E+ 00 2E+ 03 4E+ 00 0.07 7E+ 00 7E+ 04 7E+ 00 0.08 2E+ 00 6E+ 03 2E+ 00 0.00 2E+ 00 2E+ 06 2E+ 00 0.08 4E 01 4E+ 00 4E 01 0.00 P2 > P1 Risk 0.1 2E+ 00 2E+ 02 2E+ 00 0.08 6E 01 N/ A N/ A 0.00 P2 > P1 Risk 9E 01 3E+ 03 9E 01 0.07 8E 01 8E+ 02 8E 01 0.00 P2 > P1 Risk 6E 02 6E+ 01 6E 02 0.00 P2 > P1 Risk 6E 01 2E+ 01 6E 01 0.00 P2 > P1 Risk 7E 01 3E 01 7E 01 0.00 P2 > P1 Risk 0.5 2E+ 00 N/ A N/ A  0.33 2E+ 01 2E+ 04 2E+ 01 0.33 5E+ 00 1E+ 03 5E+ 00 0.00 2E+ 00 2E+ 03 2E+ 00 0.00 3E+ 00 6E+ 04 3E+ 00 0.00 8E 01 8E+ 02 8E 01 0.00 P2 > P1 Risk 4E+ 00 4E+ 06 4E+ 00 0.00 1E+ 01 3E+ 02 1E+ 01 0.33 4E+ 00 7E+ 01 4E+ 00 0.33 3E+ 01 3E+ 05 3E+ 01 0.33 4E+ 00 4E+ 03 4E+ 00 0.00 5E 01 5E+ 04 5E 01 0.00 P2 > P1 Risk 3E+ 00 3E+ 04 3E+ 00 0.00 9E 01 4E+ 03 9E 01 0.00 P2 > P1 Risk 79 Flag 95% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 95% Flag 99% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 99% Flag 90% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 90% Flag 95% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 95% Flag 99% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 99%

P2 > P1 Risk 0.1 P2 > P1 Risk 0.3 N/ A N/ A N/ A N/ A P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 0.3 P2 > P1 Risk 0.3 P2 > P1 Risk 0.2 P2 > P1 Risk 1.6 P2 Risk 1.6 P2 > P1 Risk 1.2 P2 > P1 Risk 1.9 P2 Risk 1.2 P2 Risk 1.9 P2 > P1 Risk 0.1 P2 > P1 Risk 0.2 P2 > P1 Risk N/ A N/ A N/ A N/ A P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 1.0 P2 > P1 Risk 2.9 P2 Risk 1.0 P2 Risk 2.9 N/ A N/ A N/ A N/ A P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 80 MACT Option MACT or Baseline Comparison Old P1 Category P2/ New P1 Category Chemical Grand Score Grand Score Reliability Count Zero Count P1 Count M1 OPT C BASELINE _ BASELINE COMP72 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK TEQ 0.00 3.88 1.00 0.00 0.00 OPT C BASELINE _ BASELINE COMP72 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK HG  0.25 3.38 0.75 0.00 0.25 OPT C BASELINE _ BASELINE COMP72 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK CD 0.25 3.13 0.75 0.25 0.00 OPT C BASELINE _ BASELINE COMP72 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK PB 0.25 3.13 0.75 0.25 0.00 OPT C BASELINE _ BASELINE COMP72 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK AS 0.00 3.88 1.00 0.00 0.00 OPT C BASELINE _ BASELINE COMP72 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK BE 0.25 3.13 0.71 0.25 0.00 OPT C BASELINE _ BASELINE COMP72 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK CR_ 6 0.00 3.88 0.95 0.00 0.00 OPT C BASELINE _ BASELINE COMP72 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK CR_ 3 0.25 3.13 0.75 0.25 0.00 OPT C BASELINE _ BASELINE COMP72 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK CL2 0.00 3.88 1.00 0.00 0.00 OPT C BASELINE _ BASELINE COMP72 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK HCL 0.25 3.13 0.75 0.25 0.00 OPT C BASELINE _ BASELINE COMP72 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK SB 0.00 3.88 1.00 0.00 0.00 OPT C BASELINE _ BASELINE COMP72 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK NI 0.00 3.88 0.96 0.00 0.00 OPT C BASELINE _ BASELINE COMP72 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK SE 0.00 3.88 1.00 0.00 0.00 OPT C BASELINE _ BASELINE COMP72 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK BA 0.00 3.88 1.00 0.00 0.00 OPT C BASELINE _ BASELINE COMP72 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK TL 0.00 3.88 1.00 0.00 0.00 OPT C Baseline _ MACT OPT D BASELINE _ BASELINE COMP73 ALL_ INCIN P2_ ALL_ LB TEQ 0.35 1.36 0.55 0.28 0.01 OPT D BASELINE _ BASELINE COMP73 ALL_ INCIN P2_ ALL_ LB HG 0.35 1.19 0.60 0.28 0.01 OPT D BASELINE _ BASELINE COMP73 ALL_ INCIN P2_ ALL_ LB CD 0.30 1.19 0.58 0.28 0.03 OPT D BASELINE _ BASELINE COMP73 ALL_ INCIN P2_ ALL_ LB PB 0.30 1.19 0.58 0.28 0.03 OPT D BASELINE _ BASELINE COMP73 ALL_ INCIN P2_ ALL_ LB AS  0.15 1.19 0.56 0.03 0.26 OPT D BASELINE _ BASELINE COMP73 ALL_ INCIN P2_ ALL_ LB BE  0.20 1.19 0.58 0.03 0.28 OPT D BASELINE _ BASELINE COMP73 ALL_ INCIN P2_ ALL_ LB CR_ 6  0.15 1.61 0.60 0.03 0.26 OPT D BASELINE _ BASELINE COMP73 ALL_ INCIN P2_ ALL_ LB CR_ 3  0.15 1.86 0.58 0.03 0.26 OPT D BASELINE _ BASELINE COMP73 ALL_ INCIN P2_ ALL_ LB CL2 0.20 1.56 0.81 0.06 0.01 OPT D BASELINE _ BASELINE COMP73 ALL_ INCIN P2_ ALL_ LB HCL  0.15 1.36 0.60 0.03 0.26 OPT D BASELINE _ BASELINE COMP73 ALL_ INCIN P2_ ALL_ LB SB 0.05 1.19 0.83 0.03 0.03 OPT D BASELINE _ BASELINE COMP73 ALL_ INCIN P2_ ALL_ LB NI  0.15 1.61 0.58 0.03 0.26 OPT D BASELINE _ BASELINE COMP73 ALL_ INCIN P2_ ALL_ LB SE  0.15 1.61 0.60 0.03 0.26 OPT D BASELINE _ BASELINE COMP73 ALL_ INCIN P2_ ALL_ LB BA  0.15 1.31 0.58 0.03 0.26 OPT D BASELINE _ BASELINE COMP73 ALL_ INCIN P2_ ALL_ LB TL  0.15 1.31 0.56 0.03 0.26 OPT D BASELINE _ BASELINE COMP74 ALL_ INCIN P2_ DRY_ LB TEQ 0.14 2.72 0.56 0.04 0.06 OPT D BASELINE _ BASELINE COMP75 ALL_ INCIN P2_ NOTDRY_ LB TEQ 0.41 1.41 0.46 0.29 0.01 OPT D BASELINE _ BASELINE COMP76 ALL_ INCIN P2_ ALL_ SB TEQ 0.00 2.50 0.63 0.00 0.00 OPT D BASELINE _ BASELINE COMP76 ALL_ INCIN P2_ ALL_ SB HG 0.00 3.00 0.80 0.00 0.00 OPT D BASELINE _ BASELINE COMP76 ALL_ INCIN P2_ ALL_ SB CD  0.25 2.75 0.55 0.00 0.25 81 Count 888 Count 999 P2 Pred MOE ( 50%) P2 Pred MOE/ P1 True MOE ( 50%) P2 Pred MOE ( 90%) P2 Pred MOE/ P1 True MOE ( 90%) P2 Pred MOE ( 95%)

0.00 0.00 5E+ 01 2E+ 00 7E+ 00 2E+ 00 3E+ 00 0.00 0.00 4E+ 01 7E 01 2E+ 00 7E 01 1E+ 00 0.00 0.00 2E+ 04 8E+ 00 4E+ 03 8E+ 00 2E+ 03 0.00 0.00 1E+ 03 2E+ 01 6E+ 02 2E+ 01 4E+ 02 0.00 0.00 1E+ 04 1E+ 00 1E+ 03 1E+ 00 1E+ 03 0.03 0.00 2E+ 06 7E+ 00 1E+ 05 7E+ 00 1E+ 05 0.05 0.00 3E+ 04 3E+ 00 1E+ 04 3E+ 00 7E+ 03 0.00 0.00 2E+ 07 2E+ 00 7E+ 06 2E+ 00 4E+ 06 0.00 0.00 3E+ 02 1E+ 00 2E+ 01 1E+ 00 2E+ 01 0.00 0.00 3E+ 02 3E+ 00 1E+ 02 3E+ 00 9E+ 01 0.00 0.00 7E+ 05 7E+ 00 7E+ 03 7E+ 00 7E+ 03 0.03 0.00 9E+ 04 2E+ 00 5E+ 03 2E+ 00 2E+ 03 0.00 0.00 6E+ 03 6E 01 1E+ 03 6E 01 6E+ 02 0.00 0.00 9E+ 04 2E+ 00 3E+ 03 2E+ 00 2E+ 03 0.00 0.00 6E+ 03 6E 01 3E+ 02 6E 01 6E+ 01 0.17 0.00 1E+ 03 4E+ 00 4E+ 01 4E+ 00 2E+ 01 0.12 0.00 6E+ 05 1E+ 01 3E+ 03 1E+ 01 1E+ 03 0.12 0.00 2E+ 05 9E+ 00 4E+ 03 9E+ 00 4E+ 03 0.12 0.00 2E+ 02 9E+ 00 9E+ 01 9E+ 00 9E+ 01 0.15 0.00 1E+ 03 1E 01 1E+ 01 1E 01 1E+ 01 0.12 0.00 2E+ 05 2E 01 2E+ 03 2E 01 2E+ 03 0.12 0.00 5E+ 02 5E 02 3E+ 01 5E 02 5E+ 00 0.13 0.00 1E+ 06 2E 02 6E+ 04 2E 02 4E+ 04 0.12 0.00 3E+ 02 1E+ 00 3E+ 01 1E+ 00 3E+ 01 0.12 0.00 6E+ 02 6E 02 6E+ 01 6E 02 1E+ 01 0.12 0.00 1E+ 03 1E 01 7E+ 00 1E 01 7E+ 00 0.13 0.00 2E+ 03 2E 02 5E+ 02 2E 02 2E+ 02 0.12 0.00 1E+ 05 4E 02 1E+ 03 4E 02 8E+ 02 0.13 0.00 3E+ 02 6E 04 6E+ 00 6E 04 3E+ 00 0.15 0.00 6E+ 02 6E 03 6E+ 01 6E 03 6E+ 00 0.06 0.28 1E+ 01 4E 02 4E 01 4E 02 2E 01 0.23 0.00 2E+ 03 5E+ 00 5E+ 01 5E+ 00 3E+ 01 0.03 0.34 Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE 0.03 0.18 1E+ 03 3E 02 9E+ 00 3E 02 3E+ 00 0.03 0.18 1E+ 02 7E 03 3E+ 00 7E 03 3E+ 00 82 P2 Pred MOE/ P1 True MOE ( 95%) P2 Pred MOE ( 99%) P2 Pred MOE/ P1 True MOE ( 99%) GS/ Rel 0.02 Flag 90% ( P2ucl/ P1ucl) actual/

( P2ucl/ P1ucl)

threshold 90%

2E+ 00 1E+ 00 2E+ 00 0.00 7E 01 N/ A N/ A  0.07 P2 > P1 Risk 0.5 8E+ 00 8E+ 02 8E+ 00 0.08 2E+ 01 4E+ 02 2E+ 01 0.08 1E+ 00 5E+ 02 1E+ 00 0.00 7E+ 00 7E+ 04 7E+ 00 0.08 3E+ 00 3E+ 03 3E+ 00 0.00 2E+ 00 2E+ 06 2E+ 00 0.08 1E+ 00 1E+ 01 1E+ 00 0.00 3E+ 00 6E+ 01 3E+ 00 0.08 7E+ 00 N/ A N/ A 0.00 2E+ 00 2E+ 03 2E+ 00 0.00 6E 01 6E+ 02 6E 01 0.00 P2 > P1 Risk 2E+ 00 2E+ 03 2E+ 00 0.00 6E 01 2E+ 01 6E 01 0.00 P2 > P1 Risk OPT C Baseline _ MACT 124 60 19 4E+ 00 4E+ 00 4E+ 00 0.26 1E+ 01 6E+ 02 1E+ 01 0.29 9E+ 00 2E+ 02 9E+ 00 0.25 9E+ 00 7E+ 01 9E+ 00 0.25 1E 01 6E+ 00 1E 01  0.13 P2 > P1 Risk 2E 01 5E+ 02 2E 01  0.17 P2 > P1 Risk 5E 02 1E+ 00 5E 02  0.09 P2 > P1 Risk 2E 02 2E+ 04 2E 02  0.08 P2 > P1 Risk 1E+ 00 7E+ 00 1E+ 00 0.13 6E 02 6E+ 00 6E 02  0.11 P2 > P1 Risk 1E 01 N/ A N/ A 0.04 2E 02 2E+ 01 2E 02  0.09 P2 > P1 Risk 4E 02 4E+ 02 4E 02  0.09 P2 > P1 Risk 6E 04 3E+ 00 6E 04  0.11 P2 > P1 Risk 0.2 6E 03 6E 01 6E 03  0.11 P2 > P1 Risk 4E 02 4E 02 4E 02 0.05 P2 > P1 Risk 2.5 5E+ 00 5E+ 00 5E+ 00 0.29 Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE 0.00 N/ A 3E 02 1E+ 00 3E 02 0.00 P2 > P1 Risk 0.1 7E 03 1E 01 7E 03  0.09 P2 > P1 Risk 0.3 83 Flag 95% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 95% Flag 99% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 99% Flag 90% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 90% Flag 95% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 95% Flag 99% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 99%

P2 > P1 Risk 0.7 N/ A N/ A N/ A N/ A N/ A N/ A N/ A N/ A P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 60 25 56 30 5 5 10 10 14 14 P2 > P1 Risk P2 > P1 Risk 0.2 P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 0.2 P2 > P1 Risk 1.0 P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 0.2 N/ A N/ A N/ A N/ A P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 0.3 P2 > P1 Risk 0.3 P2 > P1 Risk 0.2 P2 > P1 Risk 1.6 P2 Risk 1.6 P2 > P1 Risk 5.0 P2 > P1 Risk 25.2 P2 Risk 2.5 P2 Risk 5.0 P2 Risk 25.2 N/ A N/ A N/ A N/ A N/ A P2 > P1 Risk 0.3 P2 > P1 Risk 0.7 P2 > P1 Risk 0.3 P2 > P1 Risk 7.4 P2 Risk 7.4 84 MACT Option MACT or Baseline Comparison Old P1 Category P2/ New P1 Category Chemical Grand Score Grand Score Reliability Count Zero Count P1 Count M1 OPT D BASELINE _ BASELINE COMP76 ALL_ INCIN P2_ ALL_ SB PB 0.00 3.00 0.80 0.00 0.00 OPT D BASELINE _ BASELINE COMP76 ALL_ INCIN P2_ ALL_ SB AS 0.00 3.00 0.78 0.00 0.00 OPT D BASELINE _ BASELINE COMP76 ALL_ INCIN P2_ ALL_ SB BE 0.00 3.00 0.64 0.00 0.00 OPT D BASELINE _ BASELINE COMP76 ALL_ INCIN P2_ ALL_ SB CR_ 6 0.00 2.50 0.57 0.00 0.00 OPT D BASELINE _ BASELINE COMP76 ALL_ INCIN P2_ ALL_ SB CR_ 3 0.00 2.50 0.57 0.00 0.00 OPT D BASELINE _ BASELINE COMP76 ALL_ INCIN P2_ ALL_ SB CL2 0.00 3.00 0.64 0.00 0.00 OPT D BASELINE _ BASELINE COMP76 ALL_ INCIN P2_ ALL_ SB HCL  0.25 2.75 0.53 0.00 0.25 OPT D BASELINE _ BASELINE COMP76 ALL_ INCIN P2_ ALL_ SB SB  0.25 2.75 0.55 0.00 0.25 OPT D BASELINE _ BASELINE COMP76 ALL_ INCIN P2_ ALL_ SB NI  0.50 2.50 0.32 0.00 0.25 OPT D BASELINE _ BASELINE COMP76 ALL_ INCIN P2_ ALL_ SB SE  0.50 2.50 0.32 0.00 0.25 OPT D BASELINE _ BASELINE COMP76 ALL_ INCIN P2_ ALL_ SB BA  0.25 2.75 0.55 0.00 0.25 OPT D BASELINE _ BASELINE COMP76 ALL_ INCIN P2_ ALL_ SB TL  0.25 2.75 0.55 0.00 0.25 OPT D BASELINE _ BASELINE COMP77 ALL_ INCIN P2_ ALL_ HAF TEQ 0.01 2.95 0.83 0.02 0.01 OPT D BASELINE _ BASELINE COMP77 ALL_ INCIN P2_ ALL_ HAF HG 0.01 3.01 0.81 0.02 0.01 OPT D BASELINE _ BASELINE COMP77 ALL_ INCIN P2_ ALL_ HAF CD  0.04 3.16 0.85 0.00 0.01 OPT D BASELINE _ BASELINE COMP77 ALL_ INCIN P2_ ALL_ HAF PB 0.20 2.89 0.61 0.25 0.01 OPT D BASELINE _ BASELINE COMP77 ALL_ INCIN P2_ ALL_ HAF AS  0.04 3.16 0.85 0.00 0.01 OPT D BASELINE _ BASELINE COMP77 ALL_ INCIN P2_ ALL_ HAF BE  0.04 3.16 0.81 0.00 0.01 OPT D BASELINE _ BASELINE COMP77 ALL_ INCIN P2_ ALL_ HAF CR_ 6  0.55 1.84 0.33 0.00 0.26 OPT D BASELINE _ BASELINE COMP77 ALL_ INCIN P2_ ALL_ HAF CR_ 3  0.05 2.84 0.58 0.00 0.01 OPT D BASELINE _ BASELINE COMP77 ALL_ INCIN P2_ ALL_ HAF CL2  0.24 2.56 0.53 0.02 0.26 OPT D BASELINE _ BASELINE COMP77 ALL_ INCIN P2_ ALL_ HAF HCL  0.04 2.91 0.85 0.00 0.01 OPT D BASELINE _ BASELINE COMP77 ALL_ INCIN P2_ ALL_ HAF SB 0.04 2.64 0.72 0.04 0.02 OPT D BASELINE _ BASELINE COMP77 ALL_ INCIN P2_ ALL_ HAF NI  0.29 2.66 0.60 0.00 0.26 OPT D BASELINE _ BASELINE COMP77 ALL_ INCIN P2_ ALL_ HAF SE  0.09 3.01 0.78 0.00 0.02 OPT D BASELINE _ BASELINE COMP77 ALL_ INCIN P2_ ALL_ HAF BA  0.10 2.98 0.80 0.00 0.02 OPT D BASELINE _ BASELINE COMP77 ALL_ INCIN P2_ ALL_ HAF TL  0.34 2.76 0.58 0.00 0.27 OPT D BASELINE _ BASELINE COMP78 ALL_ INCIN NEW_ P1_ ALL_ INCIN TEQ 0.24 1.31 0.73 0.25 0.00 OPT D BASELINE _ BASELINE COMP78 ALL_ INCIN NEW_ P1_ ALL_ INCIN HG 0.00 1.56 0.99 0.00 0.00 OPT D BASELINE _ BASELINE COMP78 ALL_ INCIN NEW_ P1_ ALL_ INCIN CD 0.25 1.19 0.74 0.25 0.00 OPT D BASELINE _ BASELINE COMP78 ALL_ INCIN NEW_ P1_ ALL_ INCIN PB 0.25 1.19 0.74 0.25 0.00 OPT D BASELINE _ BASELINE COMP78 ALL_ INCIN NEW_ P1_ ALL_ INCIN AS 0.05 1.44 0.97 0.02 0.00 OPT D BASELINE _ BASELINE COMP78 ALL_ INCIN NEW_ P1_ ALL_ INCIN BE 0.25 1.44 0.74 0.25 0.00 OPT D BASELINE _ BASELINE COMP78 ALL_ INCIN NEW_ P1_ ALL_ INCIN CR_ 6 0.20 1.31 0.70 0.25 0.02 OPT D BASELINE _ BASELINE COMP78 ALL_ INCIN NEW_ P1_ ALL_ INCIN CR_ 3 0.20 1.31 0.72 0.25 0.02 OPT D BASELINE _ BASELINE COMP78 ALL_ INCIN NEW_ P1_ ALL_ INCIN CL2 0.23 1.44 0.70 0.27 0.02 OPT D BASELINE _ BASELINE COMP78 ALL_ INCIN NEW_ P1_ ALL_ INCIN HCL 0.00 1.44 0.99 0.00 0.00 85 Count 888 Count 999 P2 Pred MOE ( 50%) P2 Pred MOE/ P1 True MOE ( 50%) P2 Pred MOE ( 90%) P2 Pred MOE/ P1 True MOE ( 90%) P2 Pred MOE ( 95%)

0.03 0.18 2E 01 1E 02 1E 01 1E 02 1E 01 0.03 0.19 3E+ 01 3E 03 3E 01 3E 03 3E 01 0.03 0.34 2E+ 03 2E 03 2E+ 01 2E 03 2E+ 01 0.03 0.41 Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE 0.03 0.41 Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE 0.03 0.34 1E+ 01 6E 02 1E+ 00 6E 02 1E+ 00 0.03 0.19 3E+ 01 3E 03 3E+ 00 3E 03 6E 01 0.03 0.18 2E+ 01 2E 03 1E 01 2E 03 1E 01 0.03 0.41 1E+ 03 1E 02 2E+ 02 1E 02 1E+ 02 0.03 0.41 Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE 0.03 0.18 1E+ 02 2E 04 2E+ 00 2E 04 1E+ 00 0.03 0.18 7E+ 01 7E 04 7E+ 00 7E 04 7E 01 0.13 0.00 1E+ 01 4E 02 4E 01 4E 02 2E 01 0.16 0.00 5E+ 04 1E+ 00 3E+ 02 1E+ 00 1E+ 02 0.15 0.00 3E+ 03 1E 01 7E+ 01 1E 01 7E+ 01 0.13 0.00 6E+ 01 3E+ 00 3E+ 01 3E+ 00 3E+ 01 0.15 0.00 4E+ 03 4E 01 4E+ 01 4E 01 4E+ 01 0.18 0.00 4E+ 05 4E 01 4E+ 03 4E 01 4E+ 03 0.15 0.27 4E+ 03 4E 01 2E+ 02 4E 01 4E+ 01 0.15 0.27 8E+ 06 2E 01 5E+ 05 2E 01 3E+ 05 0.20 0.00 1E+ 01 7E 02 1E+ 00 7E 02 1E+ 00 0.15 0.00 3E+ 02 3E 02 3E+ 01 3E 02 6E+ 00 0.20 0.02 3E+ 03 3E 01 2E+ 01 3E 01 2E+ 01 0.15 0.00 8E+ 03 8E 02 2E+ 03 8E 02 8E+ 02 0.20 0.00 2E+ 04 6E 03 2E+ 02 6E 03 1E+ 02 0.16 0.02 3E+ 04 6E 02 6E+ 02 6E 02 3E+ 02 0.15 0.00 3E+ 03 3E 02 3E+ 02 3E 02 3E+ 01 0.02 0.00 2E+ 03 7E+ 00 7E+ 01 7E+ 00 3E+ 01 0.01 0.00 5E+ 04 9E 01 3E+ 02 9E 01 9E+ 01 0.01 0.00 2E+ 05 1E+ 01 6E+ 03 1E+ 01 6E+ 03 0.01 0.00 1E+ 02 7E+ 00 7E+ 01 7E+ 00 7E+ 01 0.01 0.00 2E+ 04 2E+ 00 2E+ 02 2E+ 00 2E+ 02 0.01 0.00 7E+ 05 7E 01 7E+ 03 7E 01 7E+ 03 0.03 0.00 2E+ 04 2E+ 00 1E+ 03 2E+ 00 2E+ 02 0.01 0.00 2E+ 08 3E+ 00 1E+ 07 3E+ 00 7E+ 06 0.01 0.00 5E+ 02 2E+ 00 5E+ 01 2E+ 00 5E+ 01 0.01 0.00 1E+ 04 1E+ 00 1E+ 03 1E+ 00 2E+ 02 86 P2 Pred MOE/ P1 True MOE ( 95%) P2 Pred MOE ( 99%) P2 Pred MOE/ P1 True MOE ( 99%) GS/ Rel 0.02 Flag 90% ( P2ucl/ P1ucl) actual/

( P2ucl/ P1ucl)

threshold 90%

1E 02 8E 02 1E 02 0.00 P2 > P1 Risk 9.9 3E 03 2E 01 3E 03 0.00 P2 > P1 Risk 3.2 2E 03 5E+ 00 2E 03 0.00 P2 > P1 Risk Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE 0.00 N/ A Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE 0.00 N/ A 6E 02 3E 01 6E 02 0.00 P2 > P1 Risk 0.9 3E 03 3E 01 3E 03  0.09 P2 > P1 Risk 0.4 2E 03 N/ A N/ A  0.09 P2 > P1 Risk 8.5 1E 02 1E+ 01 1E 02  0.20 P2 > P1 Risk Insufficient Data for MOE Insufficient Data for MOE Insufficient Data for MOE  0.20 N/ A 2E 04 1E+ 00 2E 04  0.09 P2 > P1 Risk 0.4 7E 04 7E 02 7E 04  0.09 P2 > P1 Risk 0.1 4E 02 4E 02 4E 02 0.00 P2 > P1 Risk 2.3 1E+ 00 5E+ 01 1E+ 00 0.00 1E 01 3E+ 00 1E 01  0.01 P2 > P1 Risk 3E+ 00 3E+ 01 3E+ 00 0.07 4E 01 2E+ 01 4E 01  0.01 P2 > P1 Risk 4E 01 1E+ 03 4E 01  0.01 P2 > P1 Risk 4E 01 8E+ 00 4E 01  0.30 P2 > P1 Risk 2E 01 2E+ 05 2E 01  0.02 P2 > P1 Risk 7E 02 4E 01 7E 02  0.09 P2 > P1 Risk 0.7 3E 02 3E+ 00 3E 02  0.01 P2 > P1 Risk 3E 01 N/ A N/ A 0.01 P2 > P1 Risk 8E 02 8E+ 01 8E 02  0.11 P2 > P1 Risk 6E 03 6E+ 01 6E 03  0.03 P2 > P1 Risk 6E 02 3E+ 02 6E 02  0.03 P2 > P1 Risk 3E 02 3E+ 00 3E 02  0.12 P2 > P1 Risk 7E+ 00 7E+ 00 7E+ 00 0.18 9E 01 5E+ 01 9E 01 0.00 P2 > P1 Risk 1E+ 01 2E+ 02 1E+ 01 0.21 7E+ 00 6E+ 01 7E+ 00 0.21 2E+ 00 1E+ 02 2E+ 00 0.03 7E 01 2E+ 03 7E 01 0.17 2E+ 00 5E+ 01 2E+ 00 0.15 3E+ 00 3E+ 06 3E+ 00 0.15 2E+ 00 1E+ 01 2E+ 00 0.16 1E+ 00 1E+ 02 1E+ 00 0.00 87 Flag 95% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 95% Flag 99% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 99% Flag 90% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 90% Flag 95% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 95% Flag 99% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 99%

P2 > P1 Risk 9.9 P2 > P1 Risk 12.4 P2 Risk 9.9 P2 Risk 9.9 P2 Risk 12.4 P2 > P1 Risk 3.2 P2 > P1 Risk 6.5 P2 Risk 3.2 P2 Risk 3.2 P2 Risk 6.5 P2 > P1 Risk P2 > P1 Risk 0.2 N/ A N/ A N/ A N/ A N/ A N/ A N/ A N/ A N/ A N/ A P2 > P1 Risk 0.9 P2 > P1 Risk 3.6 P2 Risk 3.6 P2 > P1 Risk 1.8 P2 > P1 Risk 3.5 P2 Risk 1.8 P2 Risk 3.5 P2 > P1 Risk 8.5 N/ A N/ A P2 Risk 8.5 P2 Risk 8.5 N/ A N/ A P2 > P1 Risk P2 > P1 Risk N/ A N/ A N/ A N/ A N/ A P2 > P1 Risk 0.9 P2 > P1 Risk 0.9 P2 > P1 Risk 1.4 P2 > P1 Risk 14.5 P2 Risk 1.4 P2 Risk 14.5 P2 > P1 Risk 4.6 P2 > P1 Risk 22.9 P2 Risk 2.3 P2 Risk 4.6 P2 Risk 22.9 P2 > P1 Risk P2 > P1 Risk 0.4 P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 0.1 P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 0.7 P2 > P1 Risk 2.8 P2 Risk 2.8 P2 > P1 Risk 0.2 P2 > P1 Risk 0.3 P2 > P1 Risk N/ A N/ A N/ A N/ A P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 0.4 P2 > P1 Risk P2 > P1 Risk 88 MACT Option MACT or Baseline Comparison Old P1 Category P2/ New P1 Category Chemical Grand Score Grand Score Reliability Count Zero Count P1 Count M1 OPT D BASELINE _ BASELINE COMP78 ALL_ INCIN NEW_ P1_ ALL_ INCIN SB 0.00 1.56 0.99 0.00 0.00 OPT D BASELINE _ BASELINE COMP78 ALL_ INCIN NEW_ P1_ ALL_ INCIN NI 0.25 1.31 0.72 0.25 0.00 OPT D BASELINE _ BASELINE COMP78 ALL_ INCIN NEW_ P1_ ALL_ INCIN SE  0.25 1.56 0.74 0.00 0.25 OPT D BASELINE _ BASELINE COMP78 ALL_ INCIN NEW_ P1_ ALL_ INCIN BA 0.06 1.50 0.97 0.02 0.00 OPT D BASELINE _ BASELINE COMP78 ALL_ INCIN NEW_ P1_ ALL_ INCIN TL 0.00 1.56 0.99 0.00 0.00 OPT D BASELINE _ BASELINE COMP79 ALL_ INCIN NEW_ P1_ DRY_ ALL_ INCIN TEQ  0.33 2.60 0.70 0.00 0.27 OPT D BASELINE _ BASELINE COMP80 ALL_ INCIN NEW_ P1_ NOTDRY_ ALL_ INCIN TEQ 0.25 1.49 0.66 0.25 0.00 OPT D BASELINE _ BASELINE COMP81 ALL_ INCIN P2_ ALL_ SB_ LB TEQ 0.35 1.36 0.55 0.28 0.01 OPT D BASELINE _ BASELINE COMP81 ALL_ INCIN P2_ ALL_ SB_ LB HG 0.11 1.44 0.85 0.03 0.01 OPT D BASELINE _ BASELINE COMP81 ALL_ INCIN P2_ ALL_ SB_ LB CD 0.36 1.19 0.60 0.28 0.01 OPT D BASELINE _ BASELINE COMP81 ALL_ INCIN P2_ ALL_ SB_ LB PB 0.31 1.19 0.59 0.28 0.03 OPT D BASELINE _ BASELINE COMP81 ALL_ INCIN P2_ ALL_ SB_ LB AS  0.14 1.19 0.60 0.03 0.26 OPT D BASELINE _ BASELINE COMP81 ALL_ INCIN P2_ ALL_ SB_ LB BE  0.19 1.19 0.59 0.03 0.28 OPT D BASELINE _ BASELINE COMP81 ALL_ INCIN P2_ ALL_ SB_ LB CR_ 6  0.14 1.61 0.60 0.03 0.26 OPT D BASELINE _ BASELINE COMP81 ALL_ INCIN P2_ ALL_ SB_ LB CR_ 3  0.14 1.86 0.59 0.03 0.26 OPT D BASELINE _ BASELINE COMP81 ALL_ INCIN P2_ ALL_ SB_ LB CL2 0.21 1.56 0.82 0.06 0.01 OPT D BASELINE _ BASELINE COMP81 ALL_ INCIN P2_ ALL_ SB_ LB HCL  0.14 1.36 0.60 0.03 0.26 OPT D BASELINE _ BASELINE COMP81 ALL_ INCIN P2_ ALL_ SB_ LB SB 0.11 1.19 0.85 0.03 0.01 OPT D BASELINE _ BASELINE COMP81 ALL_ INCIN P2_ ALL_ SB_ LB NI  0.14 1.49 0.60 0.03 0.26 OPT D BASELINE _ BASELINE COMP81 ALL_ INCIN P2_ ALL_ SB_ LB SE  0.14 1.61 0.60 0.03 0.26 OPT D BASELINE _ BASELINE COMP81 ALL_ INCIN P2_ ALL_ SB_ LB BA  0.14 1.19 0.57 0.03 0.26 OPT D BASELINE _ BASELINE COMP81 ALL_ INCIN P2_ ALL_ SB_ LB TL  0.14 1.19 0.57 0.03 0.26 OPT D BASELINE _ BASELINE COMP82 CK NEW_ P1_ ALL_ CK TEQ 0.31 3.19 0.73 0.27 0.00 OPT D BASELINE _ BASELINE COMP82 CK NEW_ P1_ ALL_ CK HG 0.25 3.13 0.75 0.25 0.00 OPT D BASELINE _ BASELINE COMP82 CK NEW_ P1_ ALL_ CK CD 0.25 3.13 0.75 0.25 0.00 OPT D BASELINE _ BASELINE COMP82 CK NEW_ P1_ ALL_ CK PB 0.25 3.13 0.75 0.25 0.00 OPT D BASELINE _ BASELINE COMP82 CK NEW_ P1_ ALL_ CK AS 0.00 3.88 1.00 0.00 0.00 OPT D BASELINE _ BASELINE COMP82 CK NEW_ P1_ ALL_ CK BE 0.25 3.13 0.75 0.25 0.00 OPT D BASELINE _ BASELINE COMP82 CK NEW_ P1_ ALL_ CK CR_ 6 0.00 3.88 0.94 0.00 0.00 OPT D BASELINE _ BASELINE COMP82 CK NEW_ P1_ ALL_ CK CR_ 3 0.25 3.13 0.75 0.25 0.00 OPT D BASELINE _ BASELINE COMP82 CK NEW_ P1_ ALL_ CK CL2 0.00 3.88 0.98 0.00 0.00 OPT D BASELINE _ BASELINE COMP82 CK NEW_ P1_ ALL_ CK HCL 0.25 3.13 0.75 0.25 0.00 OPT D BASELINE _ BASELINE COMP82 CK NEW_ P1_ ALL_ CK SB 0.00 3.88 1.00 0.00 0.00 OPT D BASELINE _ BASELINE COMP82 CK NEW_ P1_ ALL_ CK NI 0.00 3.88 1.00 0.00 0.00 OPT D BASELINE _ BASELINE COMP82 CK NEW_ P1_ ALL_ CK SE 0.00 3.88 1.00 0.00 0.00 OPT D BASELINE _ BASELINE COMP82 CK NEW_ P1_ ALL_ CK BA 0.00 3.88 1.00 0.00 0.00 OPT D BASELINE _ BASELINE COMP82 CK NEW_ P1_ ALL_ CK TL 0.00 3.88 1.00 0.00 0.00 89 Count 888 Count 999 P2 Pred MOE ( 50%) P2 Pred MOE/ P1 True MOE ( 50%) P2 Pred MOE ( 90%) P2 Pred MOE/ P1 True MOE ( 90%) P2 Pred MOE ( 95%)

0.01 0.00 3E+ 04 3E+ 00 1E+ 02 3E+ 00 1E+ 02 0.03 0.00 1E+ 05 1E+ 00 2E+ 04 1E+ 00 1E+ 04 0.01 0.00 2E+ 05 8E 02 2E+ 03 8E 02 2E+ 03 0.01 0.00 5E+ 05 1E+ 00 1E+ 04 1E+ 00 5E+ 03 0.01 0.00 1E+ 04 1E 01 1E+ 03 1E 01 1E+ 02 0.03 0.00 5E+ 01 2E 01 2E+ 00 2E 01 8E 01 0.09 0.00 5E+ 03 2E+ 01 2E+ 02 2E+ 01 8E+ 01 0.17 0.00 1E+ 03 4E+ 00 4E+ 01 4E+ 00 2E+ 01 0.11 0.00 7E+ 04 1E+ 00 4E+ 02 1E+ 00 1E+ 02 0.11 0.00 3E+ 04 2E+ 00 8E+ 02 2E+ 00 8E+ 02 0.11 0.00 1E+ 02 6E+ 00 6E+ 01 6E+ 00 6E+ 01 0.11 0.00 1E+ 03 1E 01 1E+ 01 1E 01 1E+ 01 0.11 0.00 2E+ 05 2E 01 2E+ 03 2E 01 2E+ 03 0.11 0.00 5E+ 02 5E 02 3E+ 01 5E 02 5E+ 00 0.13 0.00 1E+ 06 2E 02 6E+ 04 2E 02 4E+ 04 0.11 0.00 1E+ 02 6E 01 1E+ 01 6E 01 1E+ 01 0.11 0.00 4E+ 02 4E 02 4E+ 01 4E 02 8E+ 00 0.11 0.00 4E+ 03 4E 01 2E+ 01 4E 01 2E+ 01 0.11 0.00 2E+ 03 2E 02 5E+ 02 2E 02 2E+ 02 0.11 0.00 1E+ 05 4E 02 1E+ 03 4E 02 8E+ 02 0.14 0.00 3E+ 02 6E 04 6E+ 00 6E 04 3E+ 00 0.14 0.00 6E+ 02 6E 03 6E+ 01 6E 03 6E+ 00 0.00 0.00 3E+ 02 6E+ 00 3E+ 01 6E+ 00 2E+ 01 0.00 0.00 1E+ 02 2E+ 00 7E+ 00 2E+ 00 4E+ 00 0.00 0.00 2E+ 04 5E+ 00 3E+ 03 5E+ 00 2E+ 03 0.00 0.00 7E+ 02 1E+ 01 4E+ 02 1E+ 01 3E+ 02 0.00 0.00 1E+ 04 6E 01 6E+ 02 6E 01 6E+ 02 0.00 0.00 4E+ 06 4E+ 00 8E+ 04 4E+ 00 8E+ 04 0.05 0.00 2E+ 04 2E+ 00 2E+ 04 2E+ 00 2E+ 04 0.00 0.00 4E+ 07 2E+ 00 1E+ 07 2E+ 00 4E+ 06 0.02 0.00 1E+ 02 4E 01 9E+ 00 4E 01 9E+ 00 0.00 0.00 2E+ 03 2E+ 00 7E+ 02 2E+ 00 5E+ 02 0.00 0.00 6E+ 05 6E 01 6E+ 02 6E 01 6E+ 02 0.00 0.00 5E+ 04 5E 01 5E+ 03 5E 01 2E+ 03 0.00 0.00 5E+ 03 5E 01 1E+ 03 5E 01 5E+ 02 0.00 0.00 3E+ 03 6E 02 1E+ 02 6E 02 6E+ 01 0.00 0.00 3E+ 03 3E 01 2E+ 02 3E 01 3E+ 01 90 P2 Pred MOE/ P1 True MOE ( 95%) P2 Pred MOE ( 99%) P2 Pred MOE/ P1 True MOE ( 99%) GS/ Rel 0.02 Flag 90% ( P2ucl/ P1ucl) actual/

( P2ucl/ P1ucl)

threshold 90%

3E+ 00 N/ A N/ A 0.00 1E+ 00 1E+ 03 1E+ 00 0.19 8E 02 8E+ 02 8E 02  0.16 P2 > P1 Risk 1E+ 00 5E+ 03 1E+ 00 0.04 1E 01 1E+ 01 1E 01 0.00 P2 > P1 Risk 2E 01 2E 01 2E 01  0.13 P2 > P1 Risk 0.6 2E+ 01 2E+ 01 2E+ 01 0.17 4E+ 00 4E+ 00 4E+ 00 0.26 1E+ 00 7E+ 01 1E+ 00 0.08 2E+ 00 3E+ 01 2E+ 00 0.31 6E+ 00 4E+ 01 6E+ 00 0.26 1E 01 6E+ 00 1E 01  0.12 P2 > P1 Risk 2E 01 5E+ 02 2E 01  0.16 P2 > P1 Risk 5E 02 1E+ 00 5E 02  0.09 P2 > P1 Risk 2E 02 2E+ 04 2E 02  0.07 P2 > P1 Risk 6E 01 3E+ 00 6E 01 0.14 4E 02 4E+ 00 4E 02  0.10 P2 > P1 Risk 4E 01 N/ A N/ A 0.09 2E 02 2E+ 01 2E 02  0.09 P2 > P1 Risk 4E 02 4E+ 02 4E 02  0.09 P2 > P1 Risk 6E 04 3E+ 00 6E 04  0.12 P2 > P1 Risk 0.2 6E 03 6E 01 6E 03  0.12 P2 > P1 Risk 6E+ 00 9E+ 00 6E+ 00 0.10 2E+ 00 3E+ 00 2E+ 00 0.08 5E+ 00 5E+ 02 5E+ 00 0.08 1E+ 01 3E+ 02 1E+ 01 0.08 6E 01 3E+ 02 6E 01 0.00 P2 > P1 Risk 4E+ 00 4E+ 04 4E+ 00 0.08 2E+ 00 6E+ 03 2E+ 00 0.00 2E+ 00 2E+ 06 2E+ 00 0.08 4E 01 4E+ 00 4E 01 0.00 P2 > P1 Risk 0.1 2E+ 00 2E+ 02 2E+ 00 0.08 6E 01 N/ A N/ A 0.00 P2 > P1 Risk 5E 01 1E+ 03 5E 01 0.00 P2 > P1 Risk 5E 01 5E+ 02 5E 01 0.00 P2 > P1 Risk 6E 02 6E+ 01 6E 02 0.00 P2 > P1 Risk 3E 01 1E+ 01 3E 01 0.00 P2 > P1 Risk 91 Flag 95% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 95% Flag 99% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 99% Flag 90% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 90% Flag 95% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 95% Flag 99% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 99%

N/ A N/ A N/ A N/ A P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 1.3 P2 > P1 Risk 6.4 P2 Risk 1.3 P2 Risk 6.4 P2 > P1 Risk P2 > P1 Risk 0.2 P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 0.2 P2 > P1 Risk 1.0 P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 0.1 P2 > P1 Risk 0.3 N/ A N/ A N/ A N/ A P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 0.3 P2 > P1 Risk 0.3 P2 > P1 Risk 0.2 P2 > P1 Risk 1.6 P2 Risk 1.6 P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 0.1 P2 > P1 Risk 0.2 P2 > P1 Risk N/ A N/ A N/ A N/ A P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 0.1 92 MACT Option MACT or Baseline Comparison Old P1 Category P2/ New P1 Category Chemical Grand Score Grand Score Reliability Count Zero Count P1 Count M1 OPT D BASELINE _ BASELINE COMP83 LWAK NEW_ P1_ ALL_ LWAK TEQ 0.00 2.00 0.50 0.00 0.00 OPT D BASELINE _ BASELINE COMP83 LWAK NEW_ P1_ ALL_ LWAK HG 0.00 2.00 0.50 0.00 0.00 OPT D BASELINE _ BASELINE COMP83 LWAK NEW_ P1_ ALL_ LWAK CD 0.50 1.50 0.25 0.25 0.00 OPT D BASELINE _ BASELINE COMP83 LWAK NEW_ P1_ ALL_ LWAK PB 0.00 2.00 0.50 0.00 0.00 OPT D BASELINE _ BASELINE COMP83 LWAK NEW_ P1_ ALL_ LWAK AS 0.00 2.00 0.50 0.00 0.00 OPT D BASELINE _ BASELINE COMP83 LWAK NEW_ P1_ ALL_ LWAK BE 0.00 2.00 0.50 0.00 0.00 OPT D BASELINE _ BASELINE COMP83 LWAK NEW_ P1_ ALL_ LWAK CR_ 6 0.00 2.00 0.50 0.00 0.00 OPT D BASELINE _ BASELINE COMP83 LWAK NEW_ P1_ ALL_ LWAK CR_ 3 0.00 2.00 0.50 0.00 0.00 OPT D BASELINE _ BASELINE COMP83 LWAK NEW_ P1_ ALL_ LWAK CL2 0.50 1.50 0.25 0.25 0.00 OPT D BASELINE _ BASELINE COMP83 LWAK NEW_ P1_ ALL_ LWAK HCL 0.00 2.00 0.50 0.00 0.00 OPT D BASELINE _ BASELINE COMP83 LWAK NEW_ P1_ ALL_ LWAK SB 0.50 1.50 0.25 0.25 0.00 OPT D BASELINE _ BASELINE COMP83 LWAK NEW_ P1_ ALL_ LWAK NI 0.00 2.00 0.50 0.00 0.00 OPT D BASELINE _ BASELINE COMP83 LWAK NEW_ P1_ ALL_ LWAK SE 0.00 2.00 0.50 0.00 0.00 OPT D BASELINE _ BASELINE COMP83 LWAK NEW_ P1_ ALL_ LWAK BA 0.00 2.00 0.50 0.00 0.00 OPT D BASELINE _ BASELINE COMP83 LWAK NEW_ P1_ ALL_ LWAK TL 0.00 2.00 0.50 0.00 0.00 OPT D BASELINE _ BASELINE COMP84 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK TEQ 0.00 3.88 1.00 0.00 0.00 OPT D BASELINE _ BASELINE COMP84 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK HG 0.25 3.13 0.75 0.25 0.00 OPT D BASELINE _ BASELINE COMP84 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK CD 0.25 3.13 0.75 0.25 0.00 OPT D BASELINE _ BASELINE COMP84 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK PB 0.25 3.13 0.75 0.25 0.00 OPT D BASELINE _ BASELINE COMP84 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK AS 0.00 3.88 1.00 0.00 0.00 OPT D BASELINE _ BASELINE COMP84 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK BE 0.25 3.13 0.73 0.25 0.00 OPT D BASELINE _ BASELINE COMP84 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK CR_ 6 0.00 3.88 0.96 0.00 0.00 OPT D BASELINE _ BASELINE COMP84 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK CR_ 3 0.25 3.13 0.75 0.25 0.00 OPT D BASELINE _ BASELINE COMP84 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK CL2 0.00 3.88 1.00 0.00 0.00 OPT D BASELINE _ BASELINE COMP84 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK HCL 0.25 3.13 0.75 0.25 0.00 OPT D BASELINE _ BASELINE COMP84 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK SB 0.00 3.88 1.00 0.00 0.00 OPT D BASELINE _ BASELINE COMP84 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK NI 0.00 3.88 1.00 0.00 0.00 OPT D BASELINE _ BASELINE COMP84 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK SE 0.00 3.88 1.00 0.00 0.00 OPT D BASELINE _ BASELINE COMP84 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK BA 0.00 3.88 1.00 0.00 0.00 OPT D BASELINE _ BASELINE COMP84 CK_ LWAK NEW_ P1_ ALL_ CK_ LWAK TL 0.00 3.88 1.00 0.00 0.00 OPT D Baseline _ MACT 93 Count 888 Count 999 P2 Pred MOE ( 50%) P2 Pred MOE/ P1 True MOE ( 50%) P2 Pred MOE ( 90%) P2 Pred MOE/ P1 True MOE ( 90%) P2 Pred MOE ( 95%)

0.00 0.50 1E+ 01 7E 01 2E+ 00 7E 01 1E+ 00 0.00 0.50 2E+ 03 5E+ 00 2E+ 02 5E+ 00 1E+ 02 0.00 0.50 5E+ 05 3E+ 01 5E+ 04 3E+ 01 3E+ 04 0.00 0.50 5E+ 03 5E+ 00 2E+ 03 5E+ 00 2E+ 03 0.00 0.50 2E+ 04 2E+ 00 5E+ 03 2E+ 00 3E+ 03 0.00 0.50 9E+ 05 3E+ 00 2E+ 05 3E+ 00 2E+ 05 0.00 0.50 3E+ 04 8E 01 3E+ 03 8E 01 2E+ 03 0.00 0.50 4E+ 07 4E+ 00 1E+ 07 4E+ 00 7E+ 06 0.00 0.50 1E+ 04 1E+ 01 1E+ 03 1E+ 01 7E+ 02 0.00 0.50 3E+ 02 3E+ 00 1E+ 02 3E+ 00 8E+ 01 0.00 0.50 3E+ 06 3E+ 01 3E+ 05 3E+ 01 3E+ 05 0.00 0.50 2E+ 05 4E+ 00 1E+ 04 4E+ 00 4E+ 03 0.00 0.50 3E+ 05 5E 01 2E+ 05 5E 01 5E+ 04 0.00 0.50 1E+ 06 3E+ 00 6E+ 04 3E+ 00 6E+ 04 0.00 0.50 9E+ 04 9E 01 3E+ 04 9E 01 2E+ 04 0.00 0.00 5E+ 01 2E+ 00 7E+ 00 2E+ 00 3E+ 00 0.00 0.00 1E+ 02 2E+ 00 7E+ 00 2E+ 00 4E+ 00 0.00 0.00 2E+ 04 5E+ 00 3E+ 03 5E+ 00 2E+ 03 0.00 0.00 7E+ 02 1E+ 01 4E+ 02 1E+ 01 3E+ 02 0.00 0.00 1E+ 04 1E+ 00 1E+ 03 1E+ 00 1E+ 03 0.02 0.00 1E+ 06 4E+ 00 8E+ 04 4E+ 00 8E+ 04 0.04 0.00 2E+ 04 2E+ 00 6E+ 03 2E+ 00 4E+ 03 0.00 0.00 2E+ 07 2E+ 00 7E+ 06 2E+ 00 4E+ 06 0.00 0.00 3E+ 02 1E+ 00 2E+ 01 1E+ 00 2E+ 01 0.00 0.00 3E+ 02 3E+ 00 1E+ 02 3E+ 00 8E+ 01 0.00 0.00 4E+ 05 4E+ 00 4E+ 03 4E+ 00 4E+ 03 0.00 0.00 9E+ 04 2E+ 00 5E+ 03 2E+ 00 2E+ 03 0.00 0.00 6E+ 03 6E 01 1E+ 03 6E 01 6E+ 02 0.00 0.00 5E+ 04 1E+ 00 2E+ 03 1E+ 00 1E+ 03 0.00 0.00 4E+ 03 4E 01 2E+ 02 4E 01 4E+ 01 94 P2 Pred MOE/ P1 True MOE ( 95%) P2 Pred MOE ( 99%) P2 Pred MOE/ P1 True MOE ( 99%) GS/ Rel 0.02 Flag 90% ( P2ucl/ P1ucl) actual/

( P2ucl/ P1ucl)

threshold 90%

7E 01 3E 01 7E 01 0.00 P2 > P1 Risk 0.5 5E+ 00 N/ A N/ A 0.00 3E+ 01 3E+ 04 3E+ 01 0.33 5E+ 00 1E+ 03 5E+ 00 0.00 2E+ 00 2E+ 03 2E+ 00 0.00 3E+ 00 6E+ 04 3E+ 00 0.00 8E 01 8E+ 02 8E 01 0.00 P2 > P1 Risk 4E+ 00 4E+ 06 4E+ 00 0.00 1E+ 01 2E+ 02 1E+ 01 0.33 3E+ 00 6E+ 01 3E+ 00 0.00 3E+ 01 3E+ 05 3E+ 01 0.33 4E+ 00 4E+ 03 4E+ 00 0.00 5E 01 5E+ 04 5E 01 0.00 P2 > P1 Risk 3E+ 00 3E+ 04 3E+ 00 0.00 9E 01 4E+ 03 9E 01 0.00 P2 > P1 Risk 2E+ 00 1E+ 00 2E+ 00 0.00 2E+ 00 N/ A N/ A 0.08 5E+ 00 5E+ 02 5E+ 00 0.08 1E+ 01 3E+ 02 1E+ 01 0.08 1E+ 00 5E+ 02 1E+ 00 0.00 4E+ 00 4E+ 04 4E+ 00 0.08 2E+ 00 2E+ 03 2E+ 00 0.00 2E+ 00 2E+ 06 2E+ 00 0.08 1E+ 00 1E+ 01 1E+ 00 0.00 3E+ 00 6E+ 01 3E+ 00 0.08 4E+ 00 N/ A N/ A 0.00 2E+ 00 2E+ 03 2E+ 00 0.00 6E 01 6E+ 02 6E 01 0.00 P2 > P1 Risk 1E+ 00 1E+ 03 1E+ 00 0.00 4E 01 1E+ 01 4E 01 0.00 P2 > P1 Risk OPT D Baseline _ MACT 124 60 17 95 Flag 95% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 95% Flag 99% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 99% Flag 90% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 90% Flag 95% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 95% Flag 99% ( P2ucl/ P1ucl)

actual/

( P2ucl/ P1ucl)

threshold 99%

P2 > P1 Risk 1.0 P2 > P1 Risk 2.9 P2 Risk 1.0 P2 Risk 2.9 N/ A N/ A N/ A N/ A P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk N/ A N/ A N/ A N/ A N/ A N/ A N/ A N/ A P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk P2 > P1 Risk 60 23 57 30 5 5 9 9 13 13 96


[Federal Register Volume 88, Number 161 (Tuesday, August 22, 2023)]
[Notices]
[Pages 57110-57111]
[FR Doc No: 2023-18069]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. CP23-526-000]

Tennessee Gas Pipeline Company, L.L.C.; Notice of Request Under
Blanket Authorization and Establishing Intervention and Protest
Deadline

    Take notice that on August 8, 2023, Tennessee Gas Pipeline Company,
L.L.C. (Tennessee), 1001 Louisiana Street, Suite 1000, Houston, Texas
77002, filed in the above referenced docket, a prior notice request
pursuant to sections 157.205, 157.208 and 157.210 of the Commission's
regulations under the Natural Gas Act (NGA), and Tennessee's blanket
certificate issued in Docket No. CP82-413-000, for authorization to
construct its Sunnyside Supply Project. Tennessee proposes to upgrade
the existing electric motor drive for Unit 2A and to install various
enhancements at its existing Compressor Station (CS) 323A located in
Pike County, Pennsylvania. Tennessee states that the project will
increase the horsepower of Unit 2A by 2,200 horsepower (HP), bringing
the total certificated horsepower at CS 323A to 27,800 HP. Tennessee
asserts that the project will deliver 30,000 dekatherms per day of firm
transportation service to Lackawanna Energy Center LLC at an estimated
cost of approximately $15.6 million, all as more fully set forth in the
request which is on file with the Commission and open to public
inspection.
    In addition to publishing the full text of this document in the
Federal Register, the Commission provides all interested persons an
opportunity to view and/or print the contents of this document via the
internet through the Commission's Home Page (www.ferc.gov) using the
``eLibrary'' link. Enter the docket number excluding the last three
digits in the docket number field to access the document. At this time,
the Commission has suspended access to the Commission's Public
Reference Room. For assistance, contact the Federal Energy Regulatory
Commission at [email protected] or call toll-free, (886) 208-
3676 or TTY<PHONE_NUMBER>.
    Any questions concerning this request should be directed to
Francisco Tarin, Director, Regulatory, Tennessee Gas Pipeline Company,
L.L.C., Two North Nevada Avenue, Colorado Springs, Colorado 80903, by
telephone at<PHONE_NUMBER> or by email at
[email protected].

Public Participation

    There are three ways to become involved in the Commission's review
of this project: you can file a protest to the project, you can file a
motion to intervene in the proceeding, and you can file comments on the
project. There is no fee or cost for filing protests, motions to
intervene, or comments. The deadline for filing protests, motions to
intervene, and comments is 5:00 p.m. Eastern Time on October 16, 2023.
How to file protests, motions to intervene, and comments is explained
below.
    The Commission's Office of Public Participation (OPP) supports
meaningful public engagement and participation in Commission
proceedings. OPP can help members of the public, including landowners,
environmental justice communities, Tribal members and others, access
publicly available information and navigate Commission processes. For
public inquiries and assistance with making filings such as
interventions, comments, or requests for rehearing, the public is
encouraged to contact OPP at<PHONE_NUMBER> or [email protected].

Protests

    Pursuant to section 157.205 of the Commission's regulations under
the NGA,\1\ any person \2\ or the Commission's staff may file a protest
to the request. If no protest is filed within the time allowed or if a
protest is filed and then withdrawn within 30 days after the allowed
time for filing a protest, the proposed activity shall be deemed to be
authorized effective the day after the time allowed for protest. If a
protest is filed and not withdrawn within 30 days after the time
allowed for filing a protest, the instant request for authorization
will be considered by the Commission.
---------------------------------------------------------------------------

    \1\ 18 CFR 157.205.
    \2\ Persons include individuals, organizations, businesses,
municipalities, and other entities. 18 CFR 385.102(d).
---------------------------------------------------------------------------

    Protests must comply with the requirements specified in section
157.205(e) of the Commission's regulations,\3\ and must be submitted by
the protest deadline, which is October 16, 2023. A protest may also
serve as a motion to intervene so long as the protestor states it also
seeks to be an intervenor.
---------------------------------------------------------------------------

    \3\ 18 CFR 157.205(e).
---------------------------------------------------------------------------

Interventions

    Any person has the option to file a motion to intervene in this
proceeding. Only intervenors have the right to request rehearing of
Commission orders issued in this proceeding and to

subsequently challenge the Commission's orders in the U.S. Circuit
Courts of Appeal.
    To intervene, you must submit a motion to intervene to the
Commission in accordance with Rule 214 of the Commission's Rules of
Practice and Procedure \4\ and the regulations under the NGA \5\ by the
intervention deadline for the project, which is October 16, 2023. As
described further in Rule 214, your motion to intervene must state, to
the extent known, your position regarding the proceeding, as well as
your interest in the proceeding. For an individual, this could include
your status as a landowner, ratepayer, resident of an impacted
community, or recreationist. You do not need to have property directly
impacted by the project in order to intervene. For more information
about motions to intervene, refer to the FERC website at https://www.ferc.gov/resources/guides/how-to/intervene.asp.
---------------------------------------------------------------------------

    \4\ 18 CFR 385.214.
    \5\ 18 CFR 157.10.
---------------------------------------------------------------------------

    All timely, unopposed motions to intervene are automatically
granted by operation of Rule 214(c)(1). Motions to intervene that are
filed after the intervention deadline are untimely and may be denied.
Any late-filed motion to intervene must show good cause for being late
and must explain why the time limitation should be waived and provide
justification by reference to factors set forth in Rule 214(d) of the
Commission's Rules and Regulations. A person obtaining party status
will be placed on the service list maintained by the Secretary of the
Commission and will receive copies (paper or electronic) of all
documents filed by the applicant and by all other parties.

Comments

    Any person wishing to comment on the project may do so. The
Commission considers all comments received about the project in
determining the appropriate action to be taken. To ensure that your
comments are timely and properly recorded, please submit your comments
on or before October 16, 2023. The filing of a comment alone will not
serve to make the filer a party to the proceeding. To become a party,
you must intervene in the proceeding.

How to File Protests, Interventions, and Comments

    There are two ways to submit protests, motions to intervene, and
comments. In both instances, please reference the Project docket number
CP23-526-000 in your submission.
    (1) You may file your protest, motion to intervene, and comments by
using the Commission's eFiling feature, which is located on the
Commission's website (www.ferc.gov) under the link to Documents and
Filings. New eFiling users must first create an account by clicking on
``eRegister.'' You will be asked to select the type of filing you are
making; first select ``General'' and then select ``Protest'',
``Intervention'', or ``Comment on a Filing''; or \6\
---------------------------------------------------------------------------

    \6\ Additionally, you may file your comments electronically by
using the eComment feature, which is located on the Commission's
website at www.ferc.gov under the link to Documents and Filings.
Using eComment is an easy method for interested persons to submit
brief, text-only comments on a project.
---------------------------------------------------------------------------

    (2) You can file a paper copy of your submission by mailing it to
the address below. Your submission must reference the Project docket
number CP23-526-000.
    To file via USPS:

Kimberly D. Bose, Secretary, Federal Energy Regulatory Commission, 888
First Street NE, Washington, DC 20426

    To file via any other method:

Kimberly D. Bose, Secretary, Federal Energy Regulatory Commission,
12225 Wilkins Avenue, Rockville, Maryland 20852

    The Commission encourages electronic filing of submissions (option
1 above) and has eFiling staff available to assist you at (202) 502-
8258 or [email protected].
    Protests and motions to intervene must be served on the applicant
either by mail or email (with a link to the document) at: Francisco
Tarin, Director, Regulatory, Tennessee Gas Pipeline Company, L.L.C.,
Two North Nevada Avenue, Colorado Springs, Colorado 80903, or by email
at [email protected]. Any subsequent submissions by an
intervenor must be served on the applicant and all other parties to the
proceeding. Contact information for parties can be downloaded from the
service list at the eService link on FERC Online.

Tracking the Proceeding

    Throughout the proceeding, additional information about the project
will be available from the Commission's Office of External Affairs, at
(866) 208-FERC, or on the FERC website at www.ferc.gov using the
``eLibrary'' link as described above. The eLibrary link also provides
access to the texts of all formal documents issued by the Commission,
such as orders, notices, and rulemakings.
    In addition, the Commission offers a free service called
eSubscription which allows you to keep track of all formal issuances
and submittals in specific dockets. This can reduce the amount of time
you spend researching proceedings by automatically providing you with
notification of these filings, document summaries, and direct links to
the documents. For more information and to register, go to
www.ferc.gov/docs-filing/esubscription.asp.

    Dated: August 16, 2023.
Kimberly D. Bose,
Secretary.
[FR Doc. 2023-18069 Filed 8-21-23; 8:45 am]
BILLING CODE 6717-01-P